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Abstract
The cerebellum is best known for its role in controlling motor behaviors. However, recent work supports the view that it also
influences non-motor behaviors. The contribution of the cerebellum towards different brain functions is underscored by its
involvement in a diverse and increasing number of neurological and neuropsychiatric conditions including ataxia, dystonia,
essential tremor, Parkinson’s disease (PD), epilepsy, stroke, multiple sclerosis, autism spectrum disorders, dyslexia, attention
deficit hyperactivity disorder (ADHD), and schizophrenia. Although there are no cures for these conditions, cerebellar stimula-
tion is quickly gaining attention for symptomatic alleviation, as cerebellar circuitry has arisen as a promising target for invasive
and non-invasive neuromodulation. This consensus paper brings together experts from the fields of neurophysiology, neurology,
and neurosurgery to discuss recent efforts in using the cerebellum as a therapeutic intervention. We report on the most advanced
techniques for manipulating cerebellar circuits in humans and animal models and define key hurdles and questions for moving
forward.
Keywords Cerebellum . Neurostimulation . Neuromodulation . DBS . Non-invasive therapy . Optogenetics
Introduction (L.N. Miterko, J. Beckinghausen,
R.V. Sillitoe)
The cerebellum has emerged as a promising target for
neurostimulation in various diseases. Invasive cerebellar stim-
ulation in animal models reveals exciting possibilities for
work in humans and provides major hope as a novel interven-
tion for disease conditions that are severe and respond poorly
to drug treatment. Likewise, non-invasive cerebellar stimula-
tion has provided new treatment possibilities and serves to
uncover the fundamental mechanisms for how the human
brain can be modulated by exogenous stimulation. In this
consensus paper, we discuss recent animal and human stimu-
lation paradigms that targeted the cerebellum, and as a group
we attempt to identify key successes and failures, which are
critical for improvements in human therapy. We outline
important hurdles and suggest possible ways to overcome
them. Before discussing the experimental and therapeutic cer-
ebellar stimulation techniques that have been employed in
human conditions and animal models, we first revisit the basic
anatomical structure, connectivity, and function of the mam-
malian cerebellum in order to fully appreciate the outcomes of
its stimulation in health and disease.
The basic cellular composition of the cerebellum was de-
termined well over a century ago [1] and was expanded upon
in recent years by more modern techniques [2, 3]. The firing
properties of the different classes of cerebellar neurons have
been extricated by in vitro and in vivo recordings [4–6]. Its
finer connectivity was unveiled at the level of microcircuits
[7–14], patterns [15–18], and individual types of electrical and
chemical synapses using genetics, molecular biology, anato-
my, and electrophysiology [19–22]. It is therefore safe to say
that the circuitry of the cerebellum has been and still is among
the most heavily investigated structures in the entire nervous
system.
Viewed from the surface, the outer structure of the cerebel-
lum can be grossly divided into three main regions [2]. The
* Roy V. Sillitoe
sillitoe@bcm.edu
Extended author information available on the last page of the article
The Cerebellum
https://doi.org/10.1007/s12311-019-01041-5
middle portion is the vermis and is named for its worm-like
appearance. On either side of the vermis is a region called the
paravermis, which is not structurally distinct, but does contain
dedicated circuits for executing specific behaviors. The most
lateral portions of the cerebellum are adjacent to each
paravermis and are known as the hemispheres. Examination
of its surface also reveals what is perhaps the most recogniz-
able feature of the cerebellum in mammals, its highly folded
architecture. The adult cerebellum is anatomically segmented
into distinct folds called lobules [23]. There are ten primary
lobules that are separated from one another by a series of
fissures [2]. Because each fissure extends to a specific depth
in the cerebellum, each lobule develops with a unique shape.
However, all lobules contain the same canonical microcircuit.
The connectivity within the cerebellum is largely re-
peated through the structure, with each cell type forming
stereotypical connections with its neighbors [1, 2, 24].
The cerebellum has three distinct layers, and each layer
has distinct cell types (Fig. 1). The most superficial layer
contains inhibitory stellate and basket cell interneurons
and excitatory climbing and parallel fibers. These fibers
and interneuron classes project onto Purkinje cells, which
make up the middle layer called the Purkinje cell layer.
The Purkinje cell layer also contains interneurons called
candelabrum cells as well as specialized astrocytes called
Bergmann glia. The Purkinje cells contribute to relaying
the main computations of the cerebellar cortex onto
downstream nuclei. The deepest layer is called the gran-
ular layer and it contains billions of small excitatory neu-
rons called granule cells in addition to inhibitory Golgi
cells, inhibitory Lugaro cells, mossy fibers that deliver
excitatory signals to the granule cells, and a peculiar ex-
citatory cell type called the unipolar brush cell. Unlike all
other cell types that are found in all regions of the cere-
bellum, the unipolar brush cells are localized mainly in
the vermis of lobules IX and X [9]. There are also
Fig. 1 Schematic of the canonical cerebellar cortical circuit. a Cartoon
drawing of the mouse brain (left) and a sagittal section illustrating the
three layers of the cerebellar cortex (right). Schematic of the neurons in
the cerebellar cortex (bottom, enlarged) illustrating the repeating basic
circuitry that is comprised of Purkinje cells (gray), granule cells (green,
with parallel fiber axons that bifurcate in the ml), climbing fiber afferents
(blue), mossy fiber afferents (orange), stellate cell interneurons (red) and
basket cell interneurons (black), Golgi cell interneurons (magenta), and
unipolar brush cell interneurons (yellow). The excitatory synapses are
labeled with a “+” and the inhibitory synapses with a “−” sign. The
main output of the Purkinje cells is to the cerebellar nuclei, climbing
fibers derive from inferior olive neurons, and mossy fibers come from a
number of regions including the pontine nuclei, spinal cord, vestibular
nuclei, and reticular formation. For simplicity, we have not shown the
Lugaro cells or the candelabrum cells. Abbreviations: Cb = cerebellum,
ml = molecular layer, pcl = Purkinje cell layer, gl = granular layer, cn =
cerebellar nuclei, IO = inferior olive, SC = spinal cord, VN = vestibular
nuclei, RF = reticular formation
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modulatory “beaded” fibers that terminate in all layers of
all lobules [25]. Below the three layers is the white matter
that contains a dense network of fiber tracts. Embedded in
this network are three bilateral pairs of cerebellar nuclei
that are located on each side of the cerebellar midline.
These nuclei contain specialized neurons that transmit
the final output of the cerebellum, albeit that some types
have also been shown to provide axon collaterals to the
cerebellar cortex [11, 12, 26]. From medial to lateral, they
are the fastigial, interposed, and dentate nuclei, all of
which link the cerebellum to the rest of the brain and
spinal cord [24]. The interposed nuclei can be divided
into the anterior and posterior portions, which in primates
are referred to as the emboliform and globose nuclei,
respectively.
At the behavioral level, the output connections of the
cerebellar nuclei are pertinent to our discussion of cere-
bellar stimulation in health and disease. The cerebellar
nuclei project monosynaptic connections to the thalamus,
vestibular nuclei, and inferior olive and in rodents have
been shown to project to the red nucleus. The cerebellar
nuclei were also recently shown to project directly to the
locus coeruleus [27]. However, there are also polysynaptic
short latency connections with critical structures, such as
the basal ganglia [28, 29], in addition to other poorly
defined, but likely functionally very important connec-
tions to the hypothalamus [30] and hippocampus [31].
There are also several other underappreciated cerebellar
afferent pathways (e.g., cerebellar connections with the
brainstem nuclei [32]) and efferent connections (e.g., from
the periaqueductal gray [33]) that we will not discuss
here, but suffice it to say that cerebellar stimulation al-
most certainly affects many more circuits than the output
pathways to the thalamus. Furthermore, there have been
marked advances in how we think about cerebellar-
dependent behaviors. We are in unanimous and firm
agreement that the cerebellum is required for motor be-
haviors ranging from coordination, posture, and balance,
to learning and adaptation [34–37], although the exact
mechanisms are far from clear. The role of the cerebellum
is now beginning to be appreciated in behaviors previous-
ly thought to be strictly dedicated to brain regions that
process non-motor functions, including emotion, lan-
guage, and cognition [38–41]. This is an important issue
to raise because all of the cerebellar neurostimulation par-
adigms must consider the large variety of behaviors that
could potentially be affected.
Thanks to the advances in device engineering and tech-
nology, powerful pre-clinical animal models, and cutting-
edge surgical methods, our view of the cerebellum in dis-
ease therapy has considerably evolved over the past two
decades. Given that the future of brain stimulation holds
promise for a treatment or an adjuvant treatment modality,
we think this consensus paper is timely as the cerebellum
is increasingly being implicated in a growing list of neu-
rological and neuropsychiatric disorders.
However, although we think deeply towards the refine-
ment of current approaches and techniques, as well as
towards the potential for discovering future applications,
we draw heavily upon the pioneering discoveries of func-
tional neurosurgery and the initial findings of deep brain
stimulation (DBS). Seventeen brief sections follow, with
their topics spanning from different neurostimulation
methods to proposed neurostimulation mechanisms.
More specifically, we will discuss the current methods
of neurotherapeutic brain stimulation such as DBS, exper-
imental and clinically relevant methods such as transcra-
nial magnetic stimulation (TMS), transcranial direct cur-
rent stimulation (tDCS), and theta burst stimulation
(TBS), and emerging methods of stimulation such as
optogenetics, near-infrared, and magnetothermal DBS.
These methods are considered in the context of cerebellar
motor (coordination, balance, posture, learning) and non-
motor (language, social cognition, emotion, literacy ac-
quisition, attention) functions, as well as in the context
of diseases such as ataxia, dystonia, essential tremor,
Parkinson’s disease (PD), and stroke. The final sections
of this consensus paper are dedicated to discussing the
various advantages and disadvantages of cerebellar stim-
ulation, and the potential mechanisms of action.
Importantly, the systems level impact of electrical stimu-
lation on the basic activity of the cerebellar cortex and
cerebellar nuclei as well as the zonal organization of the
cerebellum are considered. We also discuss the potential
molecular impact of cerebellar stimulation.
Origins of Cerebellar Stimulation
Rationale for Cerebellar Stimulation (T. Wichmann,
M.R. DeLong)
Current DBS approaches to treating movement disorders
remain largely concentrated on efforts to influence basal
ganglia and thalamic networks. The basal ganglia has been
the favored DBS target to date because of the fact that
link(s) between activity changes in specific basal ganglia
circuits and movement disorders are relatively well-
established. For example, one of the key insights in “sys-
tems” basal ganglia research within the last decades was the
finding that the basal ganglia, thalamus, and cerebral cortex
are components of anatomical circuits with separate terri-
tories in the individual anatomical nodes of the networks
for “motor,” ‘associative,” and “limbic” functions [42, 43].
The concept of functional specificity of segregated basal
ganglia circuits provides a rationale for the neurosurgical
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targeting of specific networks for motor and non-motor dis-
orders. The clinically most important application of this
knowledge has been the use of ablative or stimulation treat-
ment applied to the basal ganglia motor circuit as treatment
for hypo- and hyperkinetic disorders [44].
However, targeting other nodes of the motor circuit,
such as the cerebellum, may also provide benefits [45].
While the cerebellum may not be as strictly segregated as
the basal ganglia into motor and non-motor territories,
there are several reasons as to why the cerebellum and
its efferents should be considered as potential DBS tar-
gets for movement disorders. One reason is, of course,
that cerebellar abnormalities have been demonstrated to
occur in movement disorders, in particular, essential or
parkinsonian tremor [36, 46–48] as well as some forms
of dystonia [49–52]. Secondly, there is already a history
of attempts to treat movement disorders with cerebellar
stimulation (see section by Wichmann and DeLong under
“Cerebe l l a r S t imu l a t i on in Humans : C l in i c a l
Applications”). Another reason to consider that modulat-
ing the activity of cerebellar targets may be useful in the
treatment of movement disorders is the finding of recent
anatomical studies in primates which showed that there
are strong bidirectional subcortical connections between
subnuclei of the basal ganglia and the cerebellum which
could have significant pathophysiological relevance for
movement disorders [36, 53, 54]. Thus, basal ganglia
activity may influence the cerebellum via projections of
the STN to pontine nuclei which then project to the cer-
ebellum [53]. In turn, projections from the deep cerebel-
lar nuclei may directly influence basal ganglia activity
via afferents to thalamic nuclei that project to the basal
ganglia (primarily the striatum [55]). These interactions
likely involve γ-aminobutric acid (GABA), glycine, glu-
tamate, and dopamine due to the cellular composition of
the deep cerebellar nuclei (GABA, glycine, glutamate
[56]) as well as the role dopamine has in facilitating
movement, learning, and non-motor behaviors in the stri-
atum and the cerebellum [57–59]. It is therefore conceiv-
able that modulating one of these systems (basal ganglia
or cerebellum) influences the other.
Cerebellar Stimulation in Animal Models:
Pre-clinical Studies
While stimulating the basal ganglia and thalamus has been
fruitful for a number of diseases, patient responses typically
vary and its implementation is restricted to treating the most
severe cases. Therefore, finding an alternative target for stim-
ulation that can normalize patient responses and extend its use
in the clinic is a top priority for clinicans and scientists alike.
To test whether the cerebellum should be considered as an
alternate stimulation target, we turn to animal models of hu-
man motor disease to assess its efficacy.
Deep Brain Stimulation in Animal Models
Implementation of Cerebellar DBS in Animal Models
(L.N. Miterko, J. Beckinghausen, A.Z. Kouzani, R.V.
Sillitoe)
Throughout Europe, Asia, and the USA, DBS is widely used
to treat both tremor and human dystonia. In the USA, DBS is
under the approval of the Food and Drug Association (FDA)
for its use in treating tremor and dystonia. The internal seg-
ment of the globus pallidus is traditionally the target for
treating dystonia with DBS [60], but patients receiving this
surgery are not always responsive to stimulation. Based on
previous and recent experimental data, there is a compelling
argument that the cerebellum should be considered as a
bonafide locus that participates in dystonia [49, 52, 61].
Therefore, we hypothesize that perhaps the reason for unre-
sponsive surgeries could be due to the stimulation site rather
than the efficacy of DBS itself [62].
To test this hypothesis, we recently used the Cre/LoxP
genetic approach to develop a new mouse model for testing
the role of the cerebellum in dystonia [63]. By selectively
silencing the glutamatergic output of olivocerebellar fibers,
we were able to successfully induce a severe dystonia that
initiated during development and continued throughout the
life of the mice [63]. These data raised the possibility that
perhaps our mice could serve as an ideal model for exam-
ining whether the cerebellar circuits for ongoing motion
were optimal targets for DBS. For this reason, we targeted
the interposed nuclei (Fig. 2), which project to several
areas, such as the red nucleus and thalamus, through which
they modulate movement. We used bilaterally implanted
twisted bipolar electrodes, and in general the approach
was inspired by the paradigms used for pre-clinical non-
human primate studies and the treatment of human PD
[64]. We reported immediate improvement in motor behav-
ior with the alleviation of twisting postures and rigidity
[63]. We also implanted DBS electrodes into the
centrolateral nucleus of the thalamus, a region implicated
in mediating the communication between the cerebellum
and basal ganglia in dystonia [29]. In accordance with the
idea of a “dystonia circuit,” high frequency stimulation of
the centrolateral nucleus also improved movement in our
mouse model of dystonia [63].
Our DBS results in rodent dystonia are promising for
human therapy, but there are many questions that should
be addressed if the cerebellum is to make it onto a
shortlist of targets for this and other motor diseases. In
the specific case of dystonia, in what circumstances
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should the cerebellum be considered for therapy? An al-
ternative question, and perhaps not mutually exclusive, is
when should globus pallidus stimulation not be the pri-
mary choice? Certainly, the neurologist and neurosurgeon
have to assess each patient and their history, but even
armed with an evaluation, these questions are still non-
trivial to address. A major consideration in this regard is
what type of dystonia the patient has, and if it is a genetic
form, is there any indication that the mutant gene and its
effects involve the cerebellum? This problem has yet to be
solved, although for Dyt1 at least there is some indication
that the genetic pathway in the cerebellum is at fault [65].
There is a long history of cerebellar stimulation for
dystonia-related behaviors [66–71], although due to
much needed regulations, progress was unfortunately tur-
bulent [72]. Still, much optimism has remained [73]. In
accordance with this, our results showing that multiple
motor features that are indicative of human dystonia are
convincingly alleviated in our mouse model of dystonia
support cerebellar stimulation for human therapy [63]. In
addition, although we showed a specific utility of inter-
posed stimulation in dystonia-like behavior, our study
was not the first demonstration of using the cerebellar
nuclei for motor repair in pre-clinical models. Elegant
work from the Machado group (see sect ion by
Cooperrider and colleagues in this Consensus) consisted
of inducing stroke in rats and then stimulating the den-
tate nucleus to improve motor outcome [74]. These stud-
ies are supported by optogenetic stimulation of the den-
tate, which also provides motor benefits ([75]; see sec-
tion by Cheng and colleagues in this Consensus). More
recently, Machado and colleagues have translated their
findings from the rodent into humans, where they are
currently testing in clinical trials if dentate nucleus stim-
ulation improves motor function after stroke (see section
by Cooperrider and colleagues in this Consensus). With
the resurgence of cerebellar nuclei stimulation as a po-
tential therapy, come many questions. The most pressing
question is, what is the mechanism of action?
Optogenetic Stimulation in Animal Models
Cerebellar Optogenetics in Stroke Research (M.Y.
Cheng, E.H. Wang, G.K. Steinberg)
Increasing brain activity can lead to the release of trophic
factors, axonal sprouting, and myelination—all of which are
beneficial for brain repair [76, 77]. Conventional brain stimu-
lation techniques such as electrical stimulation, TMS and
tDCS, allow direct manipulation of a region’s excitability
and enhance recovery after stroke [78, 79]. However, these
techniques may also induce undesirable side effects in addi-
tion to the potential functional gains. Various strategies have
been used to improve functional outcomes after stroke such as
stem cell therapies and pharmacological interventions [80,
81]. While cell therapy and drugs may catalyze endogenous
repair processes, these approaches lack the necessary spatial
resolution to precisely target specific areas.
To circumvent this, our laboratory employed optogenetics
as a tool to selectively stimulate specific cell populations after
stroke, enabling further targeting precision and the ability to
disentangle heterogeneous stimulation effects. The brain has a
remarkable capacity for plasticity after stroke, in both areas
adjacent to the infarct (the peri-infarct) and the remotely con-
nected regions [82]. Therefore, recovery from stroke likely
requires re-mapping lost function onto surviving neural cir-
cuitry through structural and functional plasticity [82, 83].
Extensive studies have focused on changes in the peri-infarct
region, including activation of an axonal sprouting program,
cellular composition changes (astrocyte and microglia prolif-
eration/migration), and neurophysiological properties [84,
85]. While some of these adaptations may exacerbate injury
such as pro-inflammatory microglia activation [86], other
changes such as increased neural excitability are positively
correlated with good functional outcomes [87].
Increasing research efforts have focused on stroke-induced
changes in remotely connected regions, including cortical
areas in the contralesional hemisphere, thalamus, and the cer-
ebellum, since stroke can disrupt neuronal function within
Fig. 2 Deep brain stimulation of the mouse cerebellum. a Cartoon
schematic of a mouse implanted with deep brain stimulation electrodes
into the cerebellum. Even though this approach uses wires to connect the
stimulator to the electrode port, there is enough flexibility for analysis in
behaving animals. b Schematic of a tissue section cut through the mouse
cerebellum illustrating the bilateral targeting of the bipolar stimulating
electrodes to the interposed (middle) nucleus (red)
Cerebellum
minutes and extend this effect to connected areas [88, 89]. In
particular, stroke can cause changes in the cortico-cerebellar
system, resulting in depression of brain metabolism and func-
tion in the cerebellum; this is known as crossed cerebellar
diaschisis [90]. In turn, this leads to dysfunction in both motor
and non-motor functions, including balance, coordination,
and visuospatial perception [90, 91]. Crossed cerebellar
diaschisis has been reported as a potential prognosis indicator
for stroke recovery [90].
Data from our laboratory and others have shown that in-
creasing excitability of the ipsilesional primary motor cortex
(iM1) after stroke is beneficial for recovery [81, 92]. Using
optogenetic neuronal stimulation, we showed that repeated
neuronal stimulation in iM1 promotes behavioral recovery in
a stroke mouse model, with an associated increase in cerebral
blood flow, neurovascular coupling response, and an increase
in neurotrophins. Importantly, stimulated mice exhibited in-
creased expression of the axonal growth associated protein 43
(GAP43), suggesting that stimulation-enhanced recovery may
enhance structural plasticity [92]. Within the cerebellum, the
lateral cerebellar nucleus (LCN) has emerged as a promising
brain stimulation target. LCN is the largest of the four cere-
bellar nuclei in primates and sends major excitatory output to
the motor, premotor, and somatosensory cortex via the
dentato-thalamo-cortical pathway [93]. Post-stroke chronic
electrical stimulations in the rat LCN have been shown to
enhance stroke recovery, with an increased expression of
markers for synaptogenesis and long-term potentiation [74].
Chronic LCN stimulations also increased neurogenesis selec-
tively in glutamatergic neurons of the motor cortex [94].
We have recently demonstrated that selective neuronal
stimulation in the contralesional LCN using optogenetic ap-
proaches resulted in robust and persistent recovery after
stroke, as stroke mice maintained their improved performance
even after cessation of stimulation for 2 weeks [75]. The per-
sistent recovery suggests that repeated LCN stimulations may
enhance structural plasticity. Examination of GAP43 expres-
sion further supports this speculation, as LCN stimulations
significantly increased the plasticity marker, GAP43, in the
ipsilesional somatosensory cortex, and its expression was pos-
itively correlated with improved functional outcomes [75].
The mechanisms of LCN stimulation-enhanced recovery like-
ly involve multiple mechanisms, including activity-dependent
molecules such as cfos and CREB, which are transcription
factors that mediate an array of downstream genes involved
in cell survival and synaptic plasticity [95]. High throughput
next generation sequencing in LCN stimulation-induced axo-
nal sprouted neurons can reveal important biological path-
ways underlying stimulation-induced recovery, which may
provide potential drug targets for enhancing stroke recovery.
The cerebellar brain stimulation studies have highlighted
LCN as a promising brain stimulation target. It is an anatom-
ically small brain region that contains widespread projections
tomultiple brain regions, thus activating this single site has the
potential to result in widespread brain activation [93]. Indeed,
our indirect comparison suggests that stimulating the LCN can
potentially be more efficacious than stimulating the motor
cortex, as LCN-stimulated mice exhibited fast and robust re-
covery. Several clinical studies support the use of LCN stim-
ulation in stroke patients. A recent study used probabilistic
tractography to demonstrate that the dentate-thalamo-cortical
tract was positively correlated to both general motor output
and fine motor skills in chronic stroke patients, further
highlighting the importance of the cerebellar dentate-
thalamo-cortical circuit [96]. A recent case study reported that
a woman with a cerebellar stroke exhibited improvements in
cerebellar ataxia after DBS in the cerebellar LCN, further
supporting the feasibility of LCN stimulation for stroke pa-
tients [97]. While using optogenetics to enhance stroke recov-
ery is highly dependent on exogenous gene therapy being
approved for use in clinical trials, our data further supports
the stimulation of the cerebellar circuit to facilitate treatments
for stroke recovery.
Cerebellar Optogenetic Stimulation for Epilepsy (S.V.
Gornati, F.E. Hoebeek)
Thus far, the diseases in which we discussed—e.g., dystonia
and stroke—have been successfully treated in rodents by stim-
ulating the cerebellar nuclei. Epilepsy is an additional neuro-
logical disease by which cerebellar stimulation holds promise.
Epilepsy is a neurological disorder characterized by episodes
of dysfunctional neuronal network activity. The seizures,
which often come about due to hyper-synchronous neuronal
firing [98], can be the result of many different causes: brain
injury, stroke, genetic mutations, and birth defects [99].
Approximately ~ 30% of epilepsy patients do not respond
adequately to anti-epileptic drugs and thus may need surgical
resection of the seizure focus, or neurostimulation. Whereas
vagal nerve stimulation is commonly used in refractory epi-
lepsy patients [100], an increasing number of patients receive
intracranial DBS [101]. However, the first brain region that
was selected for DBS in epilepsy patients was the cerebellum,
in effort to counter the hyperexcitability of thalamo-cortical
pathways [102].
Landmark studies on the origin of (excessive) thalamo-
cortical burst firing revealed that the balance between inhibi-
tion and excitation in thalamo-cortical networks is effective in
setting the firing pattern of thalamo-cortical relay neurons by
controlling the activation of low-threshold voltage-gated Ca2+
channels (as reviewed in ref [103]). Thus, by increasing the
excitatory drive onto thalamic neurons, the burst-firing of tha-
lamic relay neurons can be prevented. A recent study showed
in epileptic mouse and rat models that membrane depolariza-
tion of thalamic relay neurons prevented burst-firing and
thereby stopped generalized absence seizures [104].
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Likewise, it has also been shown in various mouse models by
pharmacological manipulation of the cerebellar nuclei neu-
rons, which form numerous glutamatergic synapses through-
out the thalamic complex, that increasing cerebellar nuclei
firing frequency dampens the occurrence of generalized ab-
sence seizures. Notably, decreasing cerebellar nuclei firing
potently increased such seizures, which contrasts initial hy-
potheses that increased inhibition of the cerebellar nuclei re-
duce seizures [105]. These findings underline the importance
of gaining precise control over the cerebellar output for opti-
mal therapeutic effects.
To ensure a temporally precise activation of inhibitory or
excitatory inputs, optogenetic stimulation is a seemingly ideal
tool. Optogenetics avoid the weakness of a-specific effects by
electrical stimulation and the temporal resolution is sufficient
to mimic endogenous activity patterns in most types of neu-
rons [106]. Moreover, by expressing light-activated proteins
like channelrhodopsin (ChR2) or halorhodopsin (HR) in spe-
cific cell types, optogenetics allow full control over action
potential firing patterns. For instance, the expression of
ChR2 in Purkinje cells, which can be induced using transgenic
mutant mice, by in utero electroporation or by viral injections
[107], allows precise control over action potential firing in
their downstream target, the cerebellar nuclei [108] and there-
by over cerebellar-evoked excitation or inhibition in the
thalamus.
Optogenetic stimulation of the cerebellar cortex has so far
been tested in two experimental studies. Krook-Magnuson
and colleagues investigated the impact of on-demand
optogenetic stimulation or inhibition of cerebellar Purkinje
cells on seizures induced by intrahippocampal kainic acid in-
jections [109]. The authors found that the seizure duration can
be shortened upon activation of ChR2- or HR channels in both
laterally and medially localized Purkinje cells, but that the
seizure occurrence could only be dampened when the midline
Purkinje cells were optogenetically excited. These findings
indicate that the cerebellar cortical stimulation, which puta-
tively stopped action potential firing in cerebellar nuclei neu-
rons, revealed therapeutic effects on limbic seizures. In con-
trast, absence seizures occur more frequently upon pharmaco-
logical inhibition of cerebellar nuclei activity [105]. Instead,
optogenetic excitation of cerebellar nuclei neurons consistent-
ly resulted in an abrupt stop of cerebral seizure activity. These
findings on the impact of cerebellar manipulations on the var-
ious types of seizures indicate that cerebellar stimulation can
have a widely varying effect on the seizure occurrence due to
how diverse innervation onto thalamic nuclei is itself by cer-
ebellar nuclei [110]. Indeed, also in the earlier reports on the
effects of low- or high-frequency stimulation (10–200 Hz), it
was noted that either seizure occurrence was dampened or
enhanced (e.g., [111]).
One potential source for the variability in effects of cere-
bellar stimulation comes from the diverse anatomical
connections that may be stimulated. Even though the
cerebello-thalamic projection is mono-synaptic and purely
glutamatergic [110], many cerebellar nuclei axons also project
to inhibitory neurons in the zona incerta and anterior pretectal
nucleus, which provide dense inhibitory input to thalamic nu-
clei [112, 113]. Thereby, the cerebellar impact on thalamic
nuclei is most likely multi-phasic, in that an optogenetically
induced increase in glutamate release from cerebellar nuclei
axons in the thalamus may be followed by an increase in
GABA. Although the impact of such feed-forward connec-
tions is currently unknown, we postulate that these speculative
multi-phasic responses in thalamus evoked by cerebellar nu-
clei stimulation aid to stop thalamo-cortical oscillations by
increasing the excitatory drive onto thalamic relay neurons
and by desynchronizing thalamo-cortical activity. It remains
to be investigated whether the impact of chronic, non-
responsive stimulation paradigms are as effective as the re-
sponsive cerebellar cortical or cerebellar nuclei stimulation
[105, 109]. Further research is also warranted to elucidate
whether cerebellar photostimulation has a broad therapeutic
effect against a variety of seizures and if optogenetics is fea-
sibly translatable to humans. For long-term use in humans,
implantable light probes must be operable and biocompatible
as well as there must be efficient delivery, retainment, and
expression of opsins in vivo to target cells with minimal ad-
verse immune responses.
Translating Cerebellar Stimulation to Humans
Cerebellar DBS in Stroke: From Pre-clinical to Clinical
Trials (J. Cooperrider, Kenneth B. Baker, A. Machado)
While pre-clinical studies in animal models have shown that
cerebellar stimulation may be beneficial in the treatment of
several diseases, including dystonia and epilepsy, its promise
as a therapy for stroke is of particular interest due to the need
for better treatments. Stroke is a devastating neurological
event that disrupts brain function and causes neuronal death.
Most stroke survivors suffer long-term deficits that range from
motor and/or sensory dysfunction to speech or memory loss,
depending on infarct site and injury severity. Post-stroke mo-
tor disability presents a substantial burden to the population,
both in terms of individual quality of life and in the social and
economic resources required to care for these patients. Current
treatment for patients with motor sequelae is largely limited to
physical therapy; however, many patients retain long-term
disabling deficits despite best efforts. As such, there has been
substantial interest in investigating the use of electrical or
magnetic stimulation of the cerebral cortex to promote post-
stroke functional recovery. Unfortunately, the efficacy of such
approaches has, thus far, been variable or limited [114]. To this
end, our group was the first to propose, research, test, and
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translate a novel neuromodulatory stimulation approach
targeting the ascending dentatothalamocortical (DTC) path-
way for post-stroke motor rehabilitation. This approach in-
volves stimulation of the cerebellar dentate nucleus, the origin
of the DTC pathway, in order to enhance activity along this
natural excitatory fiber tract and augment thalamocortical in-
teractions across multiple prefrontal, frontal, and parietal cor-
tical regions (Fig. 3). We proposed stimulation of the DTC as
part of a neuromodulation-based rehabilitation strategy for
several reasons. First, single pulse stimulation of the dentate
nucleus had been previously shown to modulate cerebral cor-
tical excitability [115–117]. We extended those findings by
showing that continuous stimulation of the dentate nucleus
produces sustained, frequency-dependent modulation of cor-
tical excitability in both naïve and post-stroke rodents [118,
119]. These results enabled our group to conclude that low-
frequency beta band stimulation might optimally enhance cor-
tical excitability and create an ideal environment for further
promoting functional reorganization and recovery. Second,
we hypothesized that chronic, exogenous activation of this
excitatory pathway could reverse the crossed cerebellar
diaschisis, and possibly even atrophic changes, that occur fol-
lowing contralateral cortical ischemia and contribute to loss of
function [90, 94, 120].
Initial studies in our lab investigated the effect of
chronic stimulation of the LCN (i.e., the homologue of
the primate dentate nucleus) in rats with large, ischemic
strokes of the middle cerebral artery, revealing significant
enhancement of motor recovery with lower frequency
stimulation [121]. Subsequent work examined whether
stimulation combined with simultaneous motor training
promotes recovery following small, cortical lesions [74,
122]. We found that dentate stimulation at 30 Hz pro-
duced significant gains in motor function compared to
control animals and significantly enhanced the expres-
sion of synaptophysin in the perilesional cortex [74,
122]. Recently, a Stanford group has replicated the
neurorestorative effect of DTC stimulation utilizing
optogenetic stimulation instead of electrical stimulation
in the mouse model [75].
In parallel with our optimization and behavioral work,
we have sought to uncover the mechanisms through
which DTC stimulation-induced recovery occurs. We
have demonstrated that post-stroke stimulation is associ-
ated with significant synaptic changes in the perilesional
cortex, including increased expression of PSD95, a mark-
er of synaptogenesis, as well as an increase in the number
of perilesional synapses [74]. DTC stimulation has also
been associated with perilesional upregulation of markers
of LTP, including CAMKII and the NMDA receptor [74].
In addition, stroked rats who received DTC stimulation
with LCN leads have altered cortical motor maps, with
increased representation of distal and proximal forelimb
and decreased representation of the unaffected limb [74].
Furthermore, stimulation has recently been shown to be
associated with increased neurogenesis in the perilesional
cortex, as well as in the mediodorsal and ventrolateral
thalamic relay nuclei, providing another mechanism
through which the facilitative effects of stimulation may
occur. Interestingly, stimulation was associated with great-
er glutamatergic and less GABAergic neurogenesis com-
pared to control animals [123]. These data indicate that
there are a number of associated microstructural, cellular,
and potentially even neuroregenerative changes associated
with DTC stimulation that may provide the mechanistic
underpinnings of this neuromodulatory therapy.
Based on these promising pre-clinical data, a first-in-
human phase I trial (Electrical Stimulation of the Dentate
Nucleus Area (EDEN) for Improvement of Upper Extremity
Hemiparesis Due to Ischemic Stroke: A Safety and Feasibility
Study) has recently received approval and is actively enrolling
(ClinicalTrials.gov Identifier: NCT02835443). This study will
Fig. 3 Deep brain stimulation of the human cerebellum. Cartoon drawing
illustrating the general approach of deep brain stimulation targeting the
dentate (lateral) nucleus in human
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evaluate the safety and feasibility of dentate nucleus
stimulation in conjunction with physical therapy in patients
with moderate to severe upper-extremity hemiparesis follow-
ing middle cerebral artery ischemia. Although significant dif-
ferences exist between the formative rodent work and human
application, initial results from the first implanted patient are
promising and have inspired an extension of the original study
timeline in order to examine not-yet-plateaued motor recov-
ery. Additionally, this clinical trial holds great promise be-
cause it has been recently shown that cerebellar modulation
via intermittent theta-burst stimulation improves gait and bal-
ance in stroke patients, possibly through neuroplasticity mech-
anisms (ClinicalTrials.gov Identifier: NCT03456362 [124]).
The dentate stimulation-associated microstructural and
neural excitability changes are currently only correlative; fu-
ture work will evaluate the causal mechanisms underlying its
therapeutic effect. Deciphering whether the functional recov-
ery achieved in pre-clinical studies is a result of stable reorga-
nization of the cortex or whether the facilitatory effects of
DTC stimulation will require continual stimulation to main-
tain benefits also needs to be examined. Future work in rodent
and non-human primate models, as well as human studies,
will also focus on optimization of stimulation timing and pa-
rameters. Finally, we postulate that stimulation of the DTC
pathway may be beneficial in improving recovery from other
types of cortical injury, including traumatic brain injury.
Results of the first-in-human trial will soon be available and
will drive future investigation.
Cerebellar Stimulation in Humans: Clinical
Applications
Clinical Experience with Electrical Cerebellar
Stimulation (T. Wichmann, M.R. DeLong)
The effects of chronic stimulation of the cerebellar cortex as a
treatment for movement disorders were explored before, by a
small number of investigators, in the setting of cerebral palsy
(CP) with spasticity and dystonia (or “athetosis,” as it was
commonly called [111, 125–144]) and epilepsy.
Cerebellar Stimulation for Treatment of Motor Dysfunction
Associated with CP The cerebellar cortex was a common tar-
get for treating the motor dysfunction(s) associated with CP
[126, 143]. Alternatively, a transtentorial or suboccipital ap-
proach was used to implant deep wire electrodes into the an-
terior lobe of the cerebellum [133, 144], or into the brachia
conjunctiva [140]. There was no consistency with regard to
the stimulation conditions. For example, early studies tended
to use chronic high frequency constant-current stimulation,
while some of the later studies used chronic intermittent
constant-voltage stimulation (e.g., 185 Hz, 210 μs, 15 min
on, 2–6 h off [144]). Cerebellar stimulation was generally
considered safe [135, 145, 146], but infections and equipment
malfunctions were frequent [132, 142].
One of the pioneers in this field, Dr. Ross Davis, reported in
2000 that 600 CP patients had been treated with cerebellar
stimulation in 18 different clinics [143]. The studies reported
improvements in spasticity and athetosis [126, 127, 132, 143,
147], as well as gait [129] and respiration [137]. In some of
these patients, the stimulation was also associated with psy-
chologic improvements, such as reductions of anxiety or im-
proved visuomotor functions [128, 140, 148]. While the re-
sults were not as impressive when studied in a double-blind
fashion (compared to the earlier unblinded studies), the
blinded studies, nevertheless, confirmed that about 2/3 to 3/4
of treated cases improved, and that at least 50% of the patients
had a reduction of spasticity by “more than 20%” [138, 139,
141]. As has been the experience in patients undergoing basal
ganglia DBS for dystonia, the effects were typically seen after
a significant delay [131].
Cerebellar Stimulation for Tremor There is emerging evidence
that cerebellar circuit abnormalities and morphologic changes
at the level of the cerebellum are important for the emergence
of kinetic tremor, such as essential tremor ([36, 46–48, 149,
150]; see section by Kuo, Xie, and Louis). In fact, lesioning or
DBS of the portion of the ventral motor thalamus (VIM) that
receives cerebellar input has been a mainstay treatment for
severe essential tremor for decades [151–154]. However, it
is not clear whether cerebellar stimulation would have simi-
larly beneficial effects, although studies of transcranial direct
current stimulation of the cerebellar cortex have had promis-
ing results ([155]; see section by Manto and Oulad Ben Taib).
Cerebellar Stimulation for Epilepsy (See Section by S.V.
Gornati, F.E. Hoebeek) In the 1940s, it was known that elec-
trical stimulation of cerebellum could control motor seizures
[156]. Partially driven by the experimental findings that the
output of the cerebellar cortex is inhibitory [157], several in-
vestigators explored how cerebellar cortical stimulation can be
used to control seizures, which were known to be driven by
cerebral hyperexcitability, by inducing inhibition. The effica-
cy of cerebellar cortical and cerebellar nuclei stimulation has
been tested for therapeutic value in a wide variety of animal
models in various species (mouse, rat, cat, and monkey) in
which seizures had been evoked by genetic manipulations,
chemical infusions, or neurostimulation approaches [158,
159]. Driven by the positive outcome of the experimental
studies on cerebellar stimulation, the first epilepsy patients
with refractory seizures were implanted with electrical stimu-
lation paddles, which were positioned on the anterior cerebel-
lar hemisphere, in the 1970s. These patients mostly received
chronic low-frequency (10 Hz) cerebellar stimulation alternat-
ing between the left- and right-side, which markedly reduced
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the frequency of seizures for up to 3 years [111]. However, the
first double-blind controlled studies of cerebellar stimulation
in five patients with refractory seizures revealed no consistent
effect of the stimulation on epileptogenic thalamo-cortical net-
works [160].
Cerebellar Stimulation for Parkinsonism and Dystonia As
mentioned above, cerebellar dysfunction is additionally impli-
cated in some aspects of PD, specifically tremor, and dystonia
[47, 49–52, 161–163], but little is known about the potential
use of cerebellar surgery for treatment of Parkinsonism and
dystonia. Indirect evidence suggests that DBS of targets in the
basal ganglia or the pedunculopontine nucleus may work best
for PD if they involve pathways that connect to the cerebellum
[164, 165], suggesting that some of the therapeutic effects of
these interventions might involve the cerebellum. Based on
limited experience with low frequency repetitive transcranial
magnetic stimulation (rTMS), cerebellar stimulation could
help with proximal movements in some PD patients, although
it may have adverse effects on fine motor skills [166]. It has
also been speculated that cerebellar stimulation could be ben-
eficial for treatment of levodopa-induced dyskinesias in PD
patients [167–169] and motor symptoms in focal dystonia
[170]. With regards to dystonia, cerebellar stimulation could
help with some aspects of this disease [171], especially with
posture, as recently shown in rodents by White and Sillitoe
(2017 [63]; see section by Miterko, Beckinghausen, Sillitoe).
As our understanding of the pathophysiology of motor dis-
ease evolves, the use of functional surgical techniques and
cerebellar stimulation may advance. Whether stimulation is
delivered through invasive (e.g., DBS) or non-invasive means
(e.g., tDCS, TMS), we are armed with new ways of targeting
the motor circuit that prioritizes patient health and optimizes
clinical outcome. In the remaining sections, we will outline
current cerebellar stimulation paradigms targeted to treat a
range of motor diseases in humans and consider their potential
mechanims so that these therapies may be optimized.
Deep Brain Stimulation in Humans
DBS in Essential Tremor (S-H Kuo, T. Xie, E.D. Louis)
Essential tremor (ET) is a progressive disease characterized by
bilateral kinetic, postural and intention tremors in the arms and
hands, and with time, these tremors become larger in ampli-
tude and slower in frequency [172]. A subset of ET patients
will also have voice tremor and head (i.e., neck) tremor. DBS
of the ventrointermediate (VIM) nucleus of the thalamus is
one of the most effective surgical options for the treatment
of ET. It can decrease tremor amplitude up to 50–80% [153]
and be effective for over 7 years [173], making it the standard
therapy for medication-refractory ET [174, 175]. However,
decreased responsiveness to VIM DBS by select body parts
(possibly due to the somatotopic organization of the VIM
nucleus) increased tolerance to VIM stimulation due to com-
pensation or disease progression [176, 177], and the develop-
ment of adverse side effects, such as dysarthia and dysphagia
[174], in patients, has driven efforts to optimize DBS
targeting.
The VIM nucleus has specific features that likely support
DBS efficacy and which would be ideal to preserve while
selecting a new target for ET. For one, the VIM nucleus re-
ceives extensive cerebellar outflow fibers from the cerebellar
nuclei [54]. Intra-operative recordings from the VIM nucleus
showed that neurons fire rhythmically at the same frequency
as the tremor [178]. Combined with the structural changes to
the Purkinje cells [179, 180], possible Purkinje cell loss [181],
Purkinje cell axonal alterations, and/or abnormal Purkinje cell
synaptic organization [182, 183] reported in postmortem hu-
man ET tissue, the VIM neurons are likely entrained by ab-
normal cerebellar activity. Further supporting the idea that the
cerebellum may be responsible for tremor generation, experi-
ments conducted with animal models of harmaline-induced
tremor have shown that enhanced coupling of the inferior
olivary neurons can produce rhythmic discharges of the down-
stream cerebellum that drive tremor [184]. Additionally, this
tremor can be effectively eliminated by VIM DBS in a
frequency- and voltage-dependent manner [185]. Although
there is no clear evidence of enhanced neuronal coupling in
the inferior olives of ET patients [186], animal models of
harmaline-induced tremor indicate that the abnormal physiol-
ogy within the cerebello-thalamo-cortical loop can produce
ET-like tremor.
The cerebello-thalamo-cortical loop is already implicat-
ed in the pathogenesis of ataxia, a clinical sign that is
frequently comorbid with tremor. For example, ET pa-
tients often have subtle cerebellar ataxia manifested by
difficulty in tandem gait [187], and a subset of ET pa-
tients will eventually develop frank ataxia [188].
However, with VIM DBS, effective tremor suppression
can sometimes come with the price of worsening gait
ataxia, a clinical observation that suggests that different
neuronal coding mechanisms for tremor and ataxia lie
within the same cerebello-thalamo-cortical loop [189].
Targeting the caudal zona incerta (cZi) and prelemniscal
radiation (Rsprl) in posterior subthalamic area (PSA)
seems to be as effective in tremor suppression as VIM
DBS, but perhaps has better tolerance and fewer side ef-
fects of dysarthria, disequilibrium, or ataxia [190]. Like
the VIM, the cZi and the Rsprl in PSA also receives
innervations from the cerebellum and other brain regions
such as the midbrain and basal ganglia. A long-term study
with bilateral DBS placed across the cZi and VIM is re-
quired to truly compare the efficacy and adverse effects of
these targets. In addition, the neuroanatomy and the
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mechanism as to why cZi or Rsprl in PSA might be su-
perior targets to VIM for neuromodulation in tremor will
need to be explored.
Since ET is a movement disorder of specific measurable
variables—frequency, phase, and amplitude—DBS of differ-
ent frequencies and currents in ET can serve as a model to
probe how brain modulation could regulate real-time move-
ments. For example, DBS may reduce tremor by regionally
modulating neuronal activities in the VIM nucleus. In turn,
this can lead to wide-spread activity changes in the brain net-
work, including the cerebellum, as evidenced by differential
cerebellar synaptic reorganization in ET cases with and with-
out DBS [191, 192]. It remains to be elucidated whether direct
stimulation of the cerebellum can equally suppress tremor or if
clinical benefits are better when intervention is earlier or adap-
tive. It is possible that stimulation of the cerebello-thalamo-
cortical loop earlier could modulate cerebellar activity and
alter the structural and degenerative changes seen in the ET
cerebellum. However, due to the progressive and wide-spread
nature of ET, early stimulation may not be enough. Since
tremor is a very unique movement disorder that can be char-
acterized by phase and frequency, current stimulation para-
digms (e.g., VIM DBS) can be optimized to these dynamics.
For example, phase-specific VIM DBS can effectively modu-
late ET frequency and amplitude [193], paving the way for the
development of adaptive DBS according to the tremor char-
acteristics in real time. In fact, phase-specific VIM DBS has
been shown to achieve tremor suppression with much less
energy requirement [194]. Recently available directional leads
would also help us to reduce energy consumption and prolong
battery life, avoid side effects related to high DBS settings,
and make more precise stimulation possible. Overall, future
adaptive DBS would deliver stimulation on demand based on
reliable biomarkers to guide automatic adjustments of stimu-
lation, which would also lead to a better understanding of the
brain circuitry of ET.
Non-invasive Stimulation in Humans
Cerebellar tDCS in Healthy Subjects and Diseased
Patients (M. Manto, N. Oulad Ben Taib)
While DBS holds promise for correcting a range of abnormal
motor behaviors in humans, it requires surgical interventions.
However, the human cerebellum is easily accessible to non-
invasive stimulation due to its anatomical location [195]. The
technique of tDCS is a non-invasive method, which is gaining
in popularity to probe and modulate cerebellar functions, both
in healthy subjects and in cerebellar disorders [196]. The re-
cently described anatomical communications between the cer-
ebellum and basal ganglia extend the potential applications of
tDCS to extra-pyramidal disorders, especially PD and
dystonia [197]. Pathological modifications in the cerebellum
circuitry, both neuropathological and functional, have been
reported in PD and likely reflect a compensatory response to
the hypofunction of the striato-thalamo-cortical pathway
[198–200].
Transcranial DCS consists of the administration of a low-
intensity current (0.5–2.5 mAmp) over the scalp with sponge
electrodes. One electrode (cathode or anode) is applied over
the cerebellum on the back of the skull, with a reference elec-
trode either on the skull (in particular: over the motor cortex,
prefrontal cortex, or over the buccinator muscle) or on the
shoulder. Cerebellar tDCS modifies the excitability of the cer-
ebellar cortex with minor side effects (mainly burning or
itching sensation). Polarity of the electrodes dictates the ef-
fects on the cerebellum [195]. Anodal tDCS excites the cere-
bellar cortex, whereas cathodal tDCS exerts an inhibitory ef-
fect. Interestingly, the technique allows the application of a
sham current. Modeling studies provide strong support for a
direct effect of tDCS upon the cerebellar circuitry and for its
remarkable containment of the current [197].
Furthermore, studies on the effects of cerebellar tDCS on
healthy patients have revealed which circuits and functions
can be modulated. Similar to DBS, tDCS impacts the cerebel-
lum, the thalamus, the basal ganglia, and the cortex, as mea-
sured by the cerebellar brain inhibition (CBI), EEG, and be-
havioral indices [201–204]. For example, tDCS has been
shown to modulate CBI in healthy subjects [205]. However,
there is no consensus regarding the impact of cerebellar tDCS
on CBI. Some authors have found a reduction of CBI follow-
ing anodal stimulation of the cerebellum [206]. Possible ex-
planations are that there is a direct effect upon the inhibitory
interneurons of the cerebellar cortex or there is an effect of the
cerebello-thalamo-projections upon the inhibitory interneu-
rons of M1. Other evidence of a physiological effect of cere-
bellar tDCS upon brain circuitry include (1) a lateralized syn-
chronization over the sensorimotor area in the gamma band
and (2) an increase of the network segregation in sensori-
motor rhythms with a greater communication between left-
right hemispheres in the gamma band, by anodal tDCS
[207]. The plastic modifications induced by cerebellar tDCS
are particularly relevant given the numerous forms of plastic-
ity encountered in the cerebellar circuitry [197]. In terms of
behavior, cerebellar tDCS improves postural control follow-
ing perturbations induced by Achilles tendon vibration and
influences also the perception of pain [203, 208].
Given the connections affected by cerebellar tDCS, this
technology holds promise for treating various motor diseases.
A recent systematic review and meta-analysis supports this by
providing evidence for a positive effect of non-invasive brain
stimulation on motor symptoms [209]. Particularly by modu-
lating the denato-cerebello-thalamic pathway and the activi-
ties of the prefrontal, parietal, and temporal lobes, the striatum,
and subthalamic nucleus [53], movement disorders such as
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essential tremor, ataxia, Parkinson’s disease, and dystonia can
be managed.
Transcranial DCS for Tremor Since tremor can be associated
with cerebellar pathology, especially at the level of the cere-
bellar cortex [210], and comorbid with ataxia, tDCS was
targeted to the cerebellum and its downstream synaptic part-
ner, the dorsolateral prefrontal cortex. Whereas the first ran-
domized, double-blind, cross-over study with bilateral cathod-
al cerebellar stimulation showed no effect on essential tremor
[155], the second study in which anodal tDCS was applied
over the dorsolateral prefrontal cortex showed an improve-
ment in ADL (i.e., Activities of Daily Living) scores and
TETRAS (i.e., The Essential Tremor Rating Assessment
Scale) scores [211]. Furthermore, tDCS over the cerebellum
immediately followed by tDCS over the contralateral motor
cortex reduces the amplitude of postural tremor and action in
tremor in SCA2 [212, 213].
Transcranial DCS for Ataxia (See Also D. Timmann, M.A.
Nitsche) Cerebellar tDCS improves ataxia by (1) reducing
the amplitudes of long-latency stretch reflexes in cerebellar
ataxias, without an effect upon short-latency stretch reflexes
[214] and (2) reduces hypermetric movements and improves
the abnormal timing of agonist-antagonist EMG bursts. This
suggests that tDCS strengthens the inhibitory effect of
Purkinje neurons upon cerebellar nuclei and that tDCS im-
proves muscle function. Furthermore, two studies from
Benussi et al. (1: single session, 2: 2 weeks’ administration;
double-blind, randomized, sham-controlled study) have
shown a symptomatic benefit on ataxia scores (SARA and
ICARS) and quantified measurements such as the 8-m walk-
ing time and performance scores from the nine-hole peg test
[215, 216]. In particular, anodal cerebellar tDCS exerts a fa-
vorable effect upon the SARA score, ICARS score, and nine-
hole peg test (9HPT) testing. A 2-weeks’ treatment with an-
odal cerebellar tDCS improves cerebellar symptoms and re-
stores CBI as compared to the sham condition. However, a
confirmatory study on a large sample of cerebellar patients is
currently missing.
Transcranial DCS for Other Movement Disorders Cerebellar
tDCS has been applied in basal ganglia disorders, in particular
PD and dystonia (see also T. Popa, M. Hallett). Anodal tDCS
applied during five consecutive days over the motor cortical
areas and the cerebellum improves the levodopa-induced dys-
kinesias in PD [217]. Cerebellar anodal tDCS improves the
kinematics of handwriting and circle drawing tasks in patients
with writing dystonia [218]. However, the effects of cerebellar
tDCS upon dystonia remain controversial [219]. Cerebellar
tDCS is promising to promote the rehabilitation for language
deficits, in particular aphasia following a stroke [220], but the
optimal location of stimulation requires to be defined. Anodal
tDCS of the right cerebellum coupled with behavioral therapy
is more efficient than behavioral therapy alone to improve
spelling and dictation [206]. Interestingly, the resting state
functional connectivityMRI data show that improved spelling
is associated with an increase in cerebello-cerebral network
connectivity. Cathodal tDCS enhances verb generation with-
out modifying verb naming in post-stroke aphasia [221].
Together, these preliminary results open the door for a
tDCS-based symptomatic management of numerous motor
disorders.
Cerebellar tDCS and Motor Learning (D. Timmann,
M.A. Nitsche)
Because of its easy application, low costs, and promising ini-
tial results, tDCS of the cerebellum has gained interest in
recent years for the treatment of ataxia and other movement
disorders [195].While the mainstay of treatment for cerebellar
ataxia is physical therapy, or motor training, accompanied by
occupational and speech therapy, neuromodulatory interven-
tions are highly desirable therapeutic supplements. Not only
does training improve cerebellar dysfunction in patients [222,
223], non-invasive brain stimulation has been shown to in-
duce and enhance plasticity, a physiological process relevant
for learning and memory formation, and is therefore a likely
candidate to enhance cerebellar-dependent learning processes
[224–226]. Transcranial DCS likely induces neuroplasticity
through modulating the excitability of the cerebellar cortex.
In accordance, cathodal tDCS reduces CBI, whereas anodal
tDCS leads to increased CBI, at least at low intensities of the
conditioning cerebellar TMS pulse [205]. The excitability of
the primary motor cortex is thereby tuned by CBI.
Ultimately, these changes to brain activity can mediate
learning, as evidenced by initial findings in reach adaptation
and eyeblink conditioning experiments, which show that
tDCS can improve both cortical and cerebellar-dependent
learning [227, 228]. For example, Galea et al. (2011) found
that anodal tDCS resulted in faster visuomotor reach adapta-
tion compared to sham stimulation in young and healthy sub-
jects [229]. Herzfeld et al. (2014) showed that anodal cerebel-
lar tDCS improved force field reach adaptation whereas cath-
odal tDCS disrupted this learning ability [230]. Similarly, lo-
comotor adaptation has been found to improve with anodal
cerebellar tDCS and decline with cathodal tDCS [231].
Furthermore, the acquisition of conditioned eyeblink re-
sponses was fostered using anodal tDCS, but deteriorated with
cathodal tDCS [232]. These results do not only imply that
cerebellar tDCS can improve learning, but deliver also rele-
vant mechanistic information. Since anodal tDCS induces
long-term potentiation (LTP)-like plasticity, and improved
learning, the results provide further evidence against the
long-standing view that long-term depression (LTD) at the
parallel fiber-Purkinje cell synapse is the only and the essential
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kind of plasticity underlying learning in the cerebellar cortex
[233]. In accordance, a recent study in mice found that anodal
tDCS effects depend on LTP and the intrinsic plasticity of
Purkinje cells in VOR habituation [234]. This has been further
supported in recent years by Johansson et al. (2015) and
Gutierres-Castellanos et al. (2017) [235, 236].
Despite the promising initial results of cerebellar anodal
tDCS on motor learning, recent studies showed that at least
some of these findings are difficult to replicate. Firstly, Hulst
et al. (2017) found no effects of neither cerebellar cathodal nor
anodal tDCS on force field reach adaptation in young controls,
elderly controls, and in patients with cerebellar degeneration
[237]. Maybe most importantly, Galea and colleagues (2017)
were unable to reproduce their initial findings in visuomotor
reach adaptation using a very similar set-up and paradigm
[238]. They found positive effects of anodal tDCS only for
adaptation of movements of the right index finger, but not of
movement of a digitizing pen (as in the original study con-
ducted by Galea et al. 2011) [229]. They were unable, how-
ever, to reproduce the respective positive finding in a second
group of young and healthy subjects. Inconsistent findings
have also been observed in eyeblink conditioning. Timmann
and colleagues (2017) were unable to reproduce their initial
strong tDCS effects in studies using the same conditioning set-
up [239]. Thus, prior to clinical applications, one needs to
understand the reasons for these inconsistent findings. One
important factor may be that effect sizes are much smaller than
expected based on the initial positive findings, because of a
bias towards publishing positive but not negative, results
[238]. Furthermore, directionality, and the amount of tDCS
effects, critically depend on the orientation of the nerve fibers,
and the highly convoluted cerebellar cortex may be a reason
that it is difficult to predict tDCS effects in an individual sub-
ject [240]. To make things even more difficult, zebrin positive
and zebrin negative zones of the cerebellar cortex appear to be
involved in different forms of motor learning (e.g., VOR ad-
aptation vs. eyeblink conditioning), and use different learning-
related plasticity mechanisms, that is LTP in zebrin positive
zones, and LTD (and other mechanisms to suppress simple
spike firing in Purkinje cells) in zebrin negative zones [241].
Thus, for cerebellar tDCS, it might be necessary to shape
stimulation protocols to allow targeted and efficient interven-
tion in future studies, including clinical applications.
To this aim, it may be helpful to develop predictors of tDCS
efficacy. Here, sensitivity for CBI might be a promising can-
didate. Similar to the effects of tDCS on the primary motor
cortex, which correlate with the sensitivity to TMS effects
[242, 243], there may be a relationship between CBI and
tDCS effects at least for certain motor learning tasks.
Furthermore, systematic optimization of stimulation proto-
cols, regarding stimulation intensity, duration, repetition rate,
targeting, electrode arrangement, and computational modeling
based on individual MRI scans to optimize stimulation
protocols at the level of the individual might be helpful to
increase efficacy of the intervention [243, 244]. For improving
the understanding of the mechanisms of action of tDCS, and
thus shape stimulation protocols on a physiology-based foun-
dation, animal experiments are needed to comprehend tDCS
effects on the level of different cerebellar layers, cell types
including inhibitory interneurons, zebrin positive and negative
zones, and the cerebellar nuclei. Finally, cerebellar tDCS ef-
fects likely depend on disease stage and ataxia type in patients
with cerebellar degeneration; thus, individual adaptation of
stimulation protocols due to the physiological and structural
state of the cerebellum might be required. These multi-level
activities are needed to systematically explore the utility of
this intervention tool beyond small-sized pilot studies.
Cerebellar Non-invasive Stimulation in Human
Dystonia (T. Popa, M. Hallett)
Non-invasive brain stimulation studies for dystonia are scarce
and an assessment of their efficacy is limited to dystonia types
in which it is possible to have EMG recordings uncontaminat-
ed by muscle contractions; that is, focal/segmental dystonia
and dystonic contractions in the setting of levodopa-induced
dyskinesia. Like cathodal tDCS for ataxia, CBI values are
decreased in eight subjects with focal hand dystonia [245].
This suggests that tDCS can similarly modulate cortical activ-
ity in dystonia.
Neuroplasticity can also be achieved by the non-invasive
brain stimulation methods of intermittent TBS and rTMS. In
healthy subjects, rTMS and tDCS can bidirectionally change
the cerebellar cortex output for at least 30 min: 1 Hz rTMS,
continuous theta burst stimulation (cTBS), or cathodal tDCS
decreases CBI, while intermittent TBS (iTBS) and anodal
tDCS strengthen it [205, 246]. When similar types of stimu-
lation are applied prior to paired associative stimulation (PAS)
with a 25-ms interval, which is a protocol to induce long-term
potentiation-like plasticity in M1, PAS can be bidirectionally
modulated: cTBScerebellum and cathodal tDCScerebellum lead to
significant enhancement of PAS-induced M1 plastic effect
above the ShamTBScerebe l lum+PASM1 level, while
iTBScerebellum and anodal tDCScerebellum lead to its abolition
[247, 248]. Interestingly, the enhancement of M1 excitability
in the target muscle of healthy volunteers with median nerve
stimulation, i.e., APB, following cTBScerebellum+PASM1 is ac-
companied by a non-specific excitability increase in an ulnar
muscle, i.e., ADM [248]—a pattern of increased plastic re-
sponse and loss of cortical map specificity similar to that de-
scribed in focal dystonia explored with PASM1 alone [249].
When this combined TBScerebellum+PASM1 paradigm was ex-
plored in patients with writer’s cramp, cerebellar cortex exci-
tation and inhibition were both ineffective in modulating PAS-
induced plasticity, suggesting a functional disconnection
[250]. When this paradigm was explored in patients with
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cervical dystonia, cerebellar cortex excitation and inhibition
induced the exact opposite modulatory effect on PAS-induced
plasticity—a pattern observed also in healthy controls volun-
tarily maintaining a turned head or maintaining the head
straight and having the sternocleidomastoid muscle vibrated
[251]. This discrepancy suggests that the apparently common
alterations in cortical excitability, sensory processing, suscep-
tibility to undergo plastic changes, and wide-scale cortico-
subcortical interactions do not have the same pathophysiology
in different types of dystonia.
This conclusion emerges also from the several attempts
made to use non-invasive stimulation of the cerebellum as
therapy for focal dystonia. All trials addressing cervical dys-
tonia obtained clinically positive, albeit modest, outcomes,
while the trials addressing focal hand dystonia did not. A
study using ten consecutive days of sham-controlled cTBS
(600 pulses) delivered bilaterally over the posterior cerebel-
lum of 20 patients with cervical dystonia led to a small (15%)
improvement of the Toronto Western Spasmodic Torticollis
Rating Scale (TWSTRS) and the recovery of the motor map
responsiveness measured as a reduction of the heterotopic
PASM1 potentiation, i.e., only APB and not FDI excitability
was responsive to PAS post-intervention [170]. In this study,
no changes were found in Burke-Fahn-Marsden Dystonia
Rating Scale, cortical silent period, intracortical inhibition/fa-
cilitation, or cerebellar-brain inhibition. The changes were
found significant immediately after the 10 therapeutic ses-
sions, but not at the 2- or 4-week follow-up post-intervention.
Another study using an identical sham-controlled design, but
with iTBScerebellum, in 16 patients found a small but significant
improvement in the severity and quality of life scores, but no
changes in the cortical neurophysiological parameters [252].
While the cTBScerebellum study normalizing the exaggerated
PASM1 effect is in line with the reversed modulation finding
[251], the iTBScerebellum study can appear counterintuitive.
Both studies need further confirmation on larger cohorts.
However, if the results of both studies are reproduced, it might
suggest that any perturbation of the cerebellar cortex might be
beneficial for cervical dystonia. A single-case, proof-of-
concept study combined botulinum toxin with anodal tDCS
in a cervical dystonia patient, applying the stimulation for
30 min, twice a week, over the right cerebellum (5 sessions),
left cerebellum (5 sessions), and right M1+left cerebellum (10
sessions), switching the stimulation site when patient reported
no benefit for two consecutive sessions [253]. The authors
reported a 39% improvement in the TWSTRS (i.e., Toronto
Western Spasmodic Torticollis Rating Scale) score and a 40%
improvement in the quality of life questionnaires from one
toxin injection to the other (12 weeks, 20 mixed-site stimula-
tion sessions) without any other neurophysiological change.
Another study reported that a single-session of cTBS over the
right cerebellum paradoxically normalized the abnormal eye-
blink classical conditioning in 10 patients with cervical
dystonia [171]. This was opposite to the degradation of eye-
blink conditioning observed in healthy subjects [254].
None of four studies using non-invasive cerebellar stimu-
lation as therapy in focal hand dystonia found any significant
clinical effect or a correlation between the neurophysiological
parameters and the arm kinematics [218, 219, 255, 256]. This
absence of acute clinical effects is not surprising especially
after only a single session of cerebellar stimulation [257]. A
common feature of deep brain stimulation of the globus
pallidus, an emerging efficient treatment for certain types of
dystonia [258], is that it often takes weeks to months for the
alleviation of symptoms to occur [259, 260]. This is in stark
contrast to other movement disorders like PD, which instantly
and reliably benefits from either DBS [261] or a few sessions
of rTMS [169, 262]. One possible explanation for this phe-
nomenon is that dystonia is a network and/or plasticity disor-
der [263], and the delay represents the time necessary for the
plastic changes to spread throughout the concerned networks.
What is surprising is to have other types of dystonia respond
acutely with clinical improvements to any kind of stimulation
[170]. This behooves us to carefully consider generalizations
of neurophysiological observations from one form of dystonia
to another, and to not discount the idea that similar abnormal-
ities (like an impaired CBI or exaggerated plastic response to
PASM1) might stem from different causes.
No explorations of the cerebellar output were attempted
with non-invasive brain stimulation in other forms of dysto-
nia. This leaves a big gap in our knowledge of the dystonic
syndromes still to be characterized from an electrophysiologic
standpoint. There is also an acute need of confirmation stud-
ies, especially regarding the clinical effects of cerebellar stim-
ulation on human disease.
Limitations of Non-invasive Stimulation
for Therapeutic Use (M. Manto, N. Oulad Ben Taib)
Although studies have indeed shown that cerebellar tDCS is a
promising treatment for a range of motor diseases, clear im-
provements are required, some of which have already been
elucidated. Besides the need for larger sample sizes and con-
firmation studies, there is also a need to clarify what the ideal
stimulation parameters are and what the patient pre-requisites
are for benefitting from stimulation. For instance, in terms of
elucidating the ideal stimulation parameters, a consensus must
be reached on identifying the montage that needs to be used,
defining the intensity and polarity of the current delivered, and
optimizing intervals between sessions and the number of ses-
sions. Furthermore, the type of disease, the duration of the
disease, and concurrent treatments (e.g., motor training, see
ref [264, 265], or pharmacotherapy, see ref [196]) might inter-
fere with stimulation efficacy [266]. Therefore, large random-
ized controlled studies are needed to establish the efficacy in
addition to a careful phenotypic characterization of cerebellar
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disorders, given their high heterogeneity. It is possible that
some patients will benefit most off-line rather than on-line to
non-invasive treatments or that efficacy is increased with pa-
tients having a greater cerebellar reserve. Efforts to assess on-
line versus off-line effects and better quantify cerebellar atro-
phy are necessary. So far, it is hypothesized that (1) on-line
benefits to stimulation might be the result of directly modu-
lating Purkinje neuron activity, whereas off-line benefits may
be the result from long-lasting changes to the activity of Golgi
cells [267, 268], and (2) severe cerebellar atrophy with a major
loss of neurons above a threshold is unlikely to respond well
to non-invasive stimulation. Stimulating patients earlier, stim-
ulating multiple sites, or delivering distinct modes of stimula-
tion [265] are being considered, but have not been validated as
viable alternative approaches, yet.
Advantages of Non-invasive Stimulation
for Therapeutic Use (L.V. Bradnam, A. McCambridge)
Non-invasive stimulation techniques—tDCS, rTMS,
TBS—as mentioned above, are relatively simplistic, por-
table, are tolerated by patients (i.e., painless and has min-
imal side effects, see ref [269, 270]), and are low cost. In
addition, these techniques require minimal training or su-
pervision, making the delivery of semi-supervised home-
based neuromodulation feasible [271], induce meaningful
clinical effects from repeated sessions alone, and are high-
ly amenable to experimentation, in both the basic and
clinical research settings. That is why tDCS, for example,
has been a primary research tool to study the motor sys-
tem, non-motor processes such as cognitive and verbal
functions, and overall cerebellar functions in both health
and disease over the past decade. Although the exact neu-
rophysiological mechanisms and resultant behavioral ef-
fects of ctDCS are not yet fully understood, we are mak-
ing strides towards this through combining anodal stimu-
lation paradigms with slice electrophysiology, eyeblink
conditioning, and paired association studies to better un-
derstand cerebellar function, brain connectivity, and be-
havioral outcomes.
The proposed mechanisms underlying anodal ctDCS-
induced neuromodulation are derived from direct current
findings in animal slices and primary motor cortex (M1)
tDCS in humans [272, 273]. Current research suggests
anodal tDCS induces a subthreshold, polarity-dependent
membrane polarization that induces neural plasticity via
N-methyl-D-aspartate, gamma-aminobutyric acid, brain-
derived neurotrophic factor, and calcium-dependent mech-
anisms [76, 274–276]. The neural circuitry underlying an-
odal ctDCS-induced effects on motor and non-motor
function is not yet known, but is thought to involve the
modulation of the cerebellar-thalamo-cortical route (see
review [195]). Anodal ctDCS may facilitate cerebellar
excitability by enhancing the inhibitory activity of
Purkinje cells onto the deep cerebellar nuclei, thereby
exerting less facilitatory drive to contralateral thalamic
nuclei and the cerebral cortex [195]. The cerebellar-
thalamo-cortical projections can be investigated in
humans using TMS. The dual-coil TMS technique, termed
CBI, delivers a conditioning TMS pulse to the cerebel-
lum, followed by a test pulse to M1 to infer inhibition
[201]. Studies have found that anodal ctDCS can influ-
ence activity in the cerebellar-thalamo-cortical pathway of
healthy subjects and patient populations using dual coil
TMS [205, 206, 215, 218].
One key study by Galea and colleagues (2009) extended
earlier experimental findings [277] by also revealing polarity-
dependent modulation of cerebellar excitability after ctDCS
[205]. Cathodal ctDCS suppressed CBI in healthy adults,
while anodal ctDCS allowed for CBI to be expressed with
lower intensities of the conditioning pulse [205]. Increased
inhibitory drive from the cerebellumwas also noted in patients
with cerebellar ataxia who underwent multiple ctDCS ses-
sions [215]. However, the opposite result was reported by
others, whereby anodal ctDCS suppressed cerebellar brain
inhibition in healthy [206] and focal hand dystonia [218]
participants.
Another method that infers cerebellar function of
ctDCS in humans is delayed eyeblink conditioning.
Based on findings in animals and support from neuroim-
aging and patient evidence, the cerebellum plays a key
role in the acquisition, timing, and retention of condi-
tioned eyeblink responses [278]. In this method, a reflex-
ive eyeblink is acquired in response to a given stimuli
(e.g., air puff) and repeatedly paired with a conditioning
stimulus (e.g., loud tone). In comparison to sham ctDCS,
the acquisition and retention of conditioned eyeblink re-
sponses after the conditioning stimulus alone was en-
hanced following anodal and reduced following cathodal
stimulation [232]. Unfortunately, the same group were
unable to replicate these findings using either a cephalic
or extracephalic electrode montage [239], highlighting the
poor understanding of the optimal stimulation parameters
for ctDCS and issues with the replicability and reliability
of ctDCS findings.
Another neurophysiological technique shown to be
partially cerebellar-dependent is paired associative stim-
ulation [247]. This technique involves repetitively pairing
peripheral nerve stimuli and M1 TMS at distinct inter-
stimulus intervals to induce LTP-like effects [279].
Anodal ctDCS blocked the induction of LTP, therefore
indicating that human associative plasticity is influenced
by the cerebellum [247]. Computational models show, as
expected, that the cerebellum is the primary structure
stimulated during ctDCS [280]. Yet further investigation
of the after-effect of ctDCS on the cerebello-thalamo-
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cortical pathway and whole brain activity using various
other methods such as neuroimaging is required.
Behavioral studies of anodal ctDCS commonly deliver
stimulation concurrently with motor training. This idea is
based on the hypothesis that increased cerebellar excitability
induced by anodal ctDCS will facilitate motor performance,
and concurrent training will enhance the functional specificity
of tDCS to the neural circuits involved [281]. Several studies
have found that anodal ctDCS can enhance the acquisition
and/or consolidation of simple motor tasks by reducing move-
ment errors [282, 283]. Interestingly, when performing a force
field reaching task, anodal ctDCS increased the ability to learn
from errors, plus form, and retain motor memory [230]. In
contrast, there was no effect of anodal ctDCS on similar motor
tasks in patients with cerebellar degeneration [237, 284]. This
may indicate the importance of an anatomically functional
cerebellum to mediate anodal ctDCS effects. The latter idea
is supported by findings of performance improvements fol-
lowing anodal ctDCS in other small patient studies. For in-
stance, anodal ctDCS improved dyskinesia scores in PD
[217], and timing of agonist commands and tremor in cerebel-
lar ataxia [212, 215, 216].
Lastly, the cerebellum is known to have a broad influ-
ence and makes a strong contribution to non-motor do-
mains such as cognition [285]. Thus, it would be expected
that anodal ctDCS would also modulate non-motor pro-
cesses. Several preliminary studies have reported positive
effects of anodal ctDCS on verbal fluency [286] and pain
perception [287] in healthy subjects and cognitive symp-
toms in Parkinson’s patients [217]. While other studies
have observed no effect on cognitive learning [288] or
memory [289], for example. A meta-analysis of cognition
studies found cognitive processes were influenced by an-
odal ctDCS but to a lesser extent than motor-related ef-
fects [290]. Whether this disparity is due to the sensitivity
of assessments or a weaker influence of the cerebellum on
cognitive processes is still uncertain.
Overall, emerging evidence provides some support for
anodal ctDCS as a neuromodulatory tool for motor and
non-motor functions. But the lack of replication is a sig-
nificant concern that must be addressed. As recommended
for tDCS research in general, the factors that underlie
inter-individual variability must first be determined, as
substantial variability will pose an additional challenge
when exploring tDCS-induced effects in inherently het-
erogeneous patient groups. Nevertheless, there are several
practical advantages of ctDCS in comparison to other
therapeutic techniques and brain stimulation protocols that
make tDCS a promising tool. And with better elucidation
of its mechanisms of action and the neuronal circuitry that
mediate reliable neurophysiological and behavioral ef-
fects, large clinical trials of the efficacy of ctDCS can
implemented.
Mechanism(s) of Cerebellar Stimulation
Potential Mechanism(s) of Action
of Neuromodulation: Lessons Learned
from Stimulating the Basal Ganglia (T. Wichmann,
M.R. DeLong)
Successful development of neuromodulation of cerebellar out-
put (alone or in combination with modulation of basal ganglia
output) relies on a better understanding of the functional
changes that occur in the cerebellum and its output pathways
in movement disorders and a better understanding of the
mechanism(s) by which neuromodulation, such as DBS,
works. Studies of the mechanisms of action of DBS have
mostly focused on basal ganglia thalamocortical circuits in
animal models and patients with PD. Although these studies
have benefited greatly from our extensive knowledge of the
pathophysiology of PD [291], a clear therapeutic principle has
not yet emerged, complicating the search for more effective
therapy targets or treatment strategies for PD (including “on
demand,” biomarker-based therapy) or other movement
disorders.
Such studies have taught us several lessons, however. One
is that the effects of electrical stimulation on brain network
activity are complex mixtures of activation and inactivation
effects that involve activity changes downstream and up-
stream from the stimulated brain area [292, 293]. Another
lesson from studies of the effects of DBS is that stimulation
of the same sensorimotor targets in the STN- and GPi-DBS
are effective in treating a variety of hypo- and hyperkinetic
movement disorders. It, thus, appears that these interventions
do not counteract specific aspects of the pathophysiology of
the individual movement disorders, but non-specifically re-
place and block abnormal activity in the basal ganglia net-
works that target the relatively intact downstream portions of
the motor circuitry [294–296].
Of course, the physiologic effects of electrical stimulation
of the basal ganglia may be very different from those that
would occur with stimulation of the cerebellum. However, if
the interactions between the cerebellum and the basal ganglia
thalamocortical circuits are of any significance in movement
disorders, it may be most effective to concentrate on the goal
of stimulating cerebellar efferents that either directly or indi-
rectly influence basal ganglia function. While the benefits
resulting from chronic stimulation of the cerebellar cortex
were significant [67, 131, 297–306], it may be easiest to focus
invasive stimulation approaches (such as DBS) on the deep
cerebellar nuclei (or on the pathways emanating from them),
given the substantial topographic spread of motor representa-
tions along the cerebellar cortex. To optimize this approach, a
good understanding of the functional connectivity of specific
deep cerebellar nuclei would be needed. The functional com-
partmentalization of the dentate nucleus into motor and non-
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motor regions [93] indicates that the precise localization of
stimulation electrodes within specific functional regions of
these nuclei could be of utmost importance for the develop-
ment of such therapies.
Limited electrophysiologic measurements made during
some of these interventions resulted in the belief that stimula-
tion of the cerebellum has inhibitory effects on thalamic areas
that receive cerebellar inputs, and on motor cortical areas [67,
297–299, 301, 302]. The effects were robust enough that sig-
nificant inhibitory effects on somatosensory-evoked potentials
were considered to be a prognostically favorable sign in pa-
tients with spasticity [300]. More recent studies have sug-
gested that, at least under certain conditions, cerebellar output
to the thalamus and cortex may instead have excitatory effects
(see other sections in this paper, and studies by [303–305]).
The method of cerebellar stimulation may explain some of the
discrepancies in the literature. For instance, while electrical
stimulation of the cerebellar cortex may have activated
Purkinje cell output to the deep cerebellar nuclei (and may,
thus, have had produced inhibitory effects in brain areas re-
ceiving cerebellar output), recent studies have suggested that
at least some forms of TMS of the cerebellum (e.g., continu-
ous theta-burst stimulation) lead to reduced cerebellar activity
([306]; see section by Popa and Hallett).
As for basal ganglia stimulation, it may not specifically
matter whether cerebellar output is increased or decreased,
as long as abnormal output from the basal ganglia (or cerebel-
lum) is prevented from reaching the cerebral cortex. With
regard to the effects of cerebellar stimulation on spasticity
and other movement disorders, it is interesting that the effects
are often delayed [131], just as they are in dystonic patients
who are treated with pallidal interventions, suggesting that the
stimulation may not only act to acutely alter synaptic trans-
mission in brain areas downstream from the stimulation, but
may lead to prominent subacute or chronic plastic changes in
thalamus or cortex. In the following four sections, we consider
these issues further, but instead from the perspective of the
basic cellular level connectivity of the cerebellar cortex and
nuclei.
Electrical Stimulation of the Cerebellar Cortex (D.H.
Heck)
Electrical stimulation of the cerebellar cortex provided among
the first insights into basic principles of cerebellar network
function in vivo [307–310] and in vitro [311, 312] was used
in elucidating key principles of cerebellar cortical interactions
with the cerebellar nuclei [10], allowed the generation of early
cerebellar motor maps (particularly oculomotor maps)
[313–318], and promised therapeutic potential [142, 319,
320]. However, a key limitation of electrical brain stimulation
exists: electrical stimulation will not primarily activate the cell
bodies of neurons surrounding the tip of the stimulation
electrode, but instead activates predominantly axons
[321–323]. This, of course, includes axons passing through
the target area and will result in a mix of antidromic and
orthodromic activation of fibers of passage as well as fibers
that do originate in the target area [324–326]. This is particu-
larly problematic when small nuclei embedded in white mat-
ter, such as the cerebellar nuclei, are the target. But this prob-
lem is also relevant for cerebellar cortical stimulation if the
electrode tip is placed at a depth where stimulation could
cause the antidromic activation of mossy fiber axons.
Stimulation of the surface of the cerebellar cortex minimizes
the risk of activating mossy fibers and will instead mostly
activate parallel fibers which will in turn provide excitatory
input to Purkinje cells and molecular layer interneurons [309].
In experiments where electrical stimuli were directly ap-
plied to the surface of the cerebellar cortex but also at various
depths below the surface, John Eccles and a group of
pioneering cerebellar electrophysiologists (1966) observed
an excitatory response that propagated along the parallel fibers
and was flanked on either side by inhibitory responses [309].
From these findings emerged the concept of the “beam” of
activated parallel fibers as a geometric representation of a
possible principle of neuronal computation in the cerebellar
cortex [309, 327]. The “beam” concept emphasized the poten-
tial functional significance of the orthogonal arrangement of
excitatory (parallel fiber) and inhibitory (stellate and basket
cell) axonal projections, a unique characteristic of the cerebel-
lar cortical network [19]. The combination of the unusual
geometrical network architecture and the characteristic simple
spike/complex spike waveforms that readily identified
Purkinje cells [328] were likely responsible for the fact that
most of the early electrophysiological investigations of cere-
bellar function focused on the cerebellar cortex, neglecting the
role of the cerebellar nuclei. However, understanding cerebel-
lar function requires understanding how the cerebellar cortex,
hence Purkinje cell activity, modulates the activity of the cer-
ebellar output neurons in the cerebellar nuclei. Electrical stim-
ulation of the cerebellar cortex in vivo combined with in vitro
experiments was used by Person and Raman (2011) to show
that synchrony in Purkinje cell firing causes synchronized
spike firing in cerebellar nuclear cells time-locked to that of
the Purkinje cells [10].
Gordon Holmes’ studies of cerebellar deficits in WWI vet-
erans (1917) had firmly established the cerebellum as a key
player in the coordination of movements, including eye move-
ments [329]. Later, electrical stimulation of the cerebellar cor-
tex (mostly in cats) was employed to determine whether motor
representation in the cerebellar cortex was topographically
organized, or whether a cerebellar motor map existed. The
results were rather complex. Cerebellar stimulation could elic-
it both simple movements and complex motor sequences, de-
pending on stimulation site, stimulus amplitude, and frequen-
cy (e.g., [313, 314]). But, while results on body and extremity
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movements were quite variable, these experiments most
prominently identified cerebellar cortical sites whose stimula-
tion reliably elicited eye movements [315–317]. Those sites
are now considered to jointly constitute the widely studied
“oculomotor” cerebellum [330].
Most applications of electrical cerebellar cortical stimula-
tion used single-site stimulation techniques and varied the
temporal characteristics and amplitude of the stimulus applied
to the site. If bipolar electrodes are used, the polarity can be
switched to move the stimulus to the other pole, but stimula-
tion is always at one site at a time. If multiple electrodes are
used, it becomes possible to generate spatio-temporal activity
patterns that allow the investigation of cerebellar network re-
sponses to dynamic events that cannot be studied with single
site stimulation. Such a multi-electrode arrangement was, for
example, used to demonstrate the ability of the cerebellar cor-
tical parallel fiber system to transform sequential inputs to the
granule cell layer into synchronous inputs to postsynaptic
Purkinje cells [312, 331].
Non-human Primates: Physiology, Lesion,
and Stimulation of Cerebellar Nuclei (M. Tanaka)
Now, interest has shifted to modulating the activity of the
cerebellar nuclei, instead of the cerebellar cortex, in hopes to
increase efficiency and reduce the variability of outcomes of
neurostimulation techniques [151]. The cerebellar nuclei have
important properties and functions that make them a promis-
ing stimulation target. For one, the cerebellar nuclei guide a
range of motor behaviors via its connectivity, activity, and
computations. On the systems-level, the cerebellar nuclei out-
puts directly regulate movement signals in the brainstem and
spinal cord, boost motor commands in the cerebral cortex via
the thalamus, and modulate signals for adaptive learning
through inhibitory projections to the inferior olive. Within
the cerebellar nuclei themselves, they usually show a high
baseline firing rate and exhibit transient activity during limb,
hand, eye, and eyelid movements [332]. Additionally, a subset
of neurons in the interposed and dentate nuclei also exhibit
sustained, preparatory activity preceding movements [333],
indicating the roles for the lateral cerebellum in motor plan-
ning [334]. Consistent with this, cerebellar lesions attenuate
cortical readiness potentials [335], and the regional blood flow
in the cerebellum correlates with the magnitude of contingent
negative variation which predicts the occurrence of relevant
events [336]. Recent studies in non-human primates demon-
strated that neurons in the cerebellar dentate nucleus exhibited
a gradual buildup of activity before self-initiated saccadic eye
movements [337, 338], and that electrical stimulation applied
to them facilitated self-timed, but not reactive, saccades [338].
Similar ramping neuronal activities were also found in the
ventrolateral (VL) thalamus [339], and inactivation of the thal-
amus delayed self-timing [340], suggesting that the
preparatory signals in the cerebellar nuclei might be sent
through the thalamus to the cortex and regulate the timing of
movement decisions. Irrespective of the length of the delay
period, neurons in the dentate nucleus always started firing
approximately a half-second before self-timed movements
[338], while those in the striatum exhibited ramping activity
throughout the delay period [341]. Since the neuronal corre-
lates of trial-by-trial variation of self-timing emerged earlier in
the cerebellum than in the striatum, the stochastic variation of
self-timing might be primarily responsible for neuronal sig-
nals in the cerebellum [341].
Computationally, the cerebellum also plays a role in
predicting sensory consequences ofmovements by calculating
prediction errors that eventually alter subsequent movements.
It has been well established that the cerebellum is essential for
adaptive motor learning, which optimizes the force and timing
of individual muscle contractions for accurate movements,
and recent studies also suggest a role for the cerebellum in
higher-order adaptive control of actions [342]. For example,
it has been shown that the error-related cortical potentials dur-
ing anti-saccades are reduced in subjects with focal cerebellar
lesions [343] and that the magnitudes of the potentials corre-
late with the volume of Crus I and II in patients with cerebellar
degeneration [344]. The other study used the stop-signal reac-
tion time task and demonstrated causal relationships between
cerebellar activity and error-related activation in the thalamus
and the supplementary motor area, which in turn correlated
with activation in the lateral prefrontal cortex during post-
error slowing [345]. These results suggest that the cerebello-
thalamo-cortical pathways may play roles in error detection
and subsequent behavioral adjustment. In monkeys, neurons
in the cerebellar dentate nucleus showed enhanced activity
during both correct and erroneous anti-saccades [346].
Inactivation of them shortened the latency and deteriorated
the accuracy of anti-saccades, while the proportion of error
trials modestly increased [346]. During tasks requiring delib-
erate control, the cerebellum may predict error in advance of
sensory feedback andmay activate the frontal cortical network
to alter behavioral strategy for subsequent movements [345],
while the cortico-basal ganglia pathways execute proactive
inhibition for the difficult tasks [347].
Besides motor control, many recent studies in humans
show cerebellar nuclei involvement in non-motor cognitive
functions [348]. Evolutionally, the lateral cerebellum is well
developed in primates, and the associated dentate nucleus in
humans comprises approximately 92% of total neurons in the
cerebellar nuclei while this proportion is 26% in cats [334].
Anatomical data show that the ventral portion of the dentate
nucleus provides signals to the association areas in the cere-
bral cortex through the thalamus, suggesting that these path-
ways are crucial for higher-order cognitive functions [91]. To
date, only a few studies have explored the neuronal correlates
of non-motor functions in the lateral cerebellum in
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experimental animals. In cats, Purkinje cells in the cerebellar
Crus I have been shown to exhibit sustained activity for a
moving object even when the object was temporarily re-
moved, indicating that these neurons represent an internal
model of external objects [349]. In monkeys, neurons in the
dentate nucleus have been shown to exhibit a gradual increase
of sensory gain when the animals attempt to detect a single
omission of isochronously presented visual stimulus (Fig. 4a;
[350, 351]). For these neurons, the inter-stimulus interval ap-
pears to be represented by the magnitude of firing modulation
for each stimulus, and the time course of neuronal activity
during each inter-stimulus interval accurately predicts timing
of the next stimulus. Inactivation of these neurons delayed
[351], and electrical stimulation promoted (Fig. 4b; [350])
the detection of stimulus omission, suggesting that they may
provide temporal prediction of stimulus occurrence, which is
needed to compute prediction error for the absence of regular
stimuli [352]. Similar to the time course of neuronal activity in
the cerebellar nuclei, temporally specific periodic signals
predicting event timing have also been reported in the beta-
band coherence of neuromagnetic activity between the cere-
bellum and the cerebral cortex when listening to an auditory
beat [353], suggesting that such signals may provide a basis
for the perception of rhythms. For temporal information pro-
cessing, another line of evidence also suggests that the cere-
bellummight play a role in Bayesian inference of event timing
[354, 355], although the underlying neuronal mechanism
needs to be clarified in future studies in experimental animals.
Cerebellar Compartmentalization: the Likely
Involvement of Zones and Stripes
in Neuromodulation (L.N. Miterko, J. Beckinghausen,
R.V. Sillitoe)
Evidently, the largest hurdle to overcome will be to solve the
mechanism of action in DBS, for each circuit, in each disease.
From a general perspective, the cellular, circuit, and network
effects of DBS have been debated at length [294, 356], and
there are several different aspects of a potential “cerebellar
mechanism” that could be discussed. Above, we discuss the
effects of modulating cerebellar cortical and cerebellar nuclei
activity on circuit functioning and behavior. Here, we would
like to consider a possible mechanism from the view of the
normal internal organization of the cerebellum.
All aspects of cerebellar development, function, behavior,
and in many cases disease are organized around a striking
array of parasagittal stripe domains, or zones as they are often
called [3, 24, 357, 358]. At the center of each stripe are the
Purkinje cells, the sole output of the cerebellar cortex.
Remarkably, more than 30 years ago, it was recognized that
stimulating adjacent regions of the cerebellar cortex—or the
stripes—resulted in different behavioral outcomes in cerebral
palsy patients that showed symptoms of dystonia [140]. These
neurosurgical data are supported by electrophysiology studies
in non-human primates showing that the normal cerebellum
controls co-contractions of agonist and antagonist muscle ac-
tivity [359], as well as transsynaptic retrograde tracing of the
muscles that reveal connections to Purkinje cell stripes in rats
[360]. The key to this architecture is that the Purkinje cell
stripes and their associated climbing fiber inputs operate as
synchronous units [361, 362]. The synchronous activity is
processed within the deep nuclei, but here the signals from
Purkinje cells must converge [10]. Thus, what type of activity
are we tapping into when we stimulate the cerebellar nuclei
using DBS? There are likely retrograde effects within the cer-
ebellar cortex itself, but it would be interesting to test whether
the responses within the thalamus and other downstream tar-
gets operate according to the topography that originates from
within the cerebellum. If this is true, one must reconsider the
possibility that cerebellar DBS could have incredibly variant
effects depending on which specific sets of cerebellar zonal
modules are recruited. These effects could manifest at the
Fig. 4 Electrical stimulation to
the dentate nucleus advances
sensory prediction. a Neurons in
the dentate nucleus exhibited
firing modulation when the
monkey attempted to detect a
single omission of periodic visual
stimuli. b Electrical stimulation
applied to the recording site
shortened the reaction time for the
stimulus omission. Adapted with
permission from [350]
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levels of cells, molecules, and circuits, which all contribute to
the cerebellar zonal map. The use of conditional mouse genet-
ics combined with optogenetics and DREADD approaches
lend themselves to testing these possibilities in different dis-
ease models. Furthermore, optogenetic stimulation, as used by
Gornati, Hoebeek, Cheng, Wang, and Steinberg for epilepsy
and stroke, can help us understand cerebellar involvement in
disease and cerebellar plasticity during rehabilitation. We al-
ready know that cerebellar DBS [74] and optogenetics [75]
may be both effective as therapies, in addition to can be ad-
justed to mimic the parameters of one another [363]. Closed-
loop DBS [364] as well as closed-loop optogenetic [365]
methods could be very effective at elucidating cellular bio-
markers in disease. As the techniques become more integrated
and sophisticated, one could consider approaches such as
near-infrared light technology alone or combined with
optogenetics [366]. The complexity of the zonal cerebellar
circuitry as well as its wide-spread connectivity in motor and
non-motor behavior necessitate an equal level of sophistica-
tion in examining the responses to cerebellar stimulation. It
will be imperative that single-unit electrophysiology ap-
proaches are used to analyze the cell-specific details of neuro-
nal responses downstream of stimulation, but also population-
level responses will have to be collected using tools such as
tetrodes, array electrodes, silicone probes, or even fiber pho-
tometry and deep tissue endoscopy.
The Potential Molecular Mechanisms Underlying
the Efficacy of Cerebellar Stimulation (L.N. Miterko,
R.V. Sillitoe)
The various mechanisms by which neurostimulation elicits
large-scale, behavioral responses range from inducing plastic-
ity to modulating local and global neural network activity, as
previously discussed by Bradnam, McCambridge, Wichmann,
DeLong, Heck, Tanaka, and colleagues, and regardless of the
paradigm (i.e., tDCS, electrical stimulation, lesioning,
optogenetics). While changes in plasticity and local or
systems-level electrophysiological properties depend on what
is being activated (axons vs. somata) and the region-specific
functions that are being capitalized on by neurostimulation,
there are common molecular threads that underlie learning
and neural communication. For example, learning is a process
shared among neurons throughout different brain regions and
involves an increase in the influx of intracellular Ca2+ so that
receptors involved in learning (e.g., mGluR1) can be activated.
In turn, the activation of learning receptors can induce ultra-
structural changes in the neuron, especially at the synapse (e.g.,
greater spine density), to promote sustained activity. Also com-
mon among neurons is their ability to communicate with one
another. The release of neurotransmitters is a critical feature of
action potential propagation and can be specific to the behavior
by facilitating communication between cells in particular
neural circuits. For instance, dopamine and serotonin can reg-
ulate emotion and support feelings of addiction and reward.
Furthermore, cholinergic signaling is commonly associated
with satiating hunger and glutamatergic signaling is commonly
associated with learning and memory. While the roles of neu-
rotransmitters are dynamic, and can switch depending on age
and circumstance, the fact that neurotransmitter classes are
well-elucidated, and we are learningmore andmore about their
contributions to health and disease, creates optimism that we
can uncover the molecular mechanism(s) of neurostimulation.
However, it is still not clear whether neurostimulation ap-
proaches simply piggy back on the endogenous molecular
pathways or whether stimulation in fact hijacks one or more
pathways to shape neural activity for behavioral improvement.
Efforts to elucidate the molecular mechanisms of
neurostimulation approaches transcend methods and brain
regions. Of much interest to scientists and clinicians alike
is how deep brain stimulation works since this is an FDA-
approved method that is already readily employed in
humans. Early studies on the molecular mechanisms of
PD entailed a combination of fast cyclic voltammetry
(FSCV), microdialysis, high performance liquid chroma-
tography electrochemical detection (HPLC-ECD), and
functional imaging (PET) [367, 368]. Increased tyrosine
hydroxylase (TH) expression accompanied increased do-
pamine in the striatum of Parkinsonian rats after STN stim-
ulation [367, 368]. Furthermore, behavioral improvements
were documented after STN stimulation increased dopa-
mine metabolism [368, 369]. However, these results were
not reproducible in humans [370], and even if they were, it
would not explain why DBS works despite patient resis-
tance to dopaminergic drugs. Fluctuating serotonin levels
have recently been implicated in the after-effects of STN
DBS due to data reporting that (1) cognitive and depressive
symptoms develop after stimulation and (2) anti-
Parkinsonian drugs reduce serotonin in the prefrontal cor-
tex and hippocampus, and (3) selective serotonin reuptake
inhibitors (SSRIs) such as fluoxetine enhance responsive-
ness to neurostimulation [371–373].
While measuring neurotransmitter concentration and imag-
ing its release gave insight into possible molecular mecha-
nisms of DBS, more sophisticated methods have been devel-
oped to analyze molecular and genetic changes that occur on
the single-cell level. Forniceal DBS is one example where
quantitative PCR, RNA-sequencing, bisulfite sequencing,
and proteomics were performed to address how electrical
stimulation improves learning, memory, and promotes
neurogenesis, as previously found by and Hao, Shirvalker,
and colleagues [374–376]. Through a combination of these
molecular and stimulation techniques, Pohodich et al. (2018)
found that forniceal DBS in mouse upregulates genes in-
volved in cell survival, synaptic function, and neurogenesis,
specifically through Jun signaling [374]. These data are
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particularly interesting since earlier stimulation studies sup-
port the role of DBS in promoting neurogenesis through find-
ings that electrical fields can (1) selectively direct the migra-
tion of stem cells [377–379], (2) increase blood flow [380],
and (3) modulate neural networks (see sections by
Cooperrider, Manto and Oulad Ben Taib, Bradnam and
McCambridge, Popa and Hallett, and Timmann and Nitsche).
Are the molecular insights we have gained from studying
STN and forniceal DBS applicable to cerebellar stimulation?
There is a breadth of evidence suggesting that there may be
some similarities. Not only does stimulating the cerebellum
result in increased plasticity (see section by Cooperider and
colleagues), it has also been found to be associated with do-
pamine release [381], increased blood flow [382, 383], non-
motor relief [384], and modulatory effects on global neural
networks [202, 385, 386]. Despite these shared properties, it
is likely that molecular profiles diverge, especially as the par-
adigm changes. For instance, different locations (e.g., dentate
vs. interposed vs. fastigal nuclei), frequencies (e.g., low vs.
high), and pathologies most likely elicit different molecular
changes in order to achieve improvements in varied behaviors.
Studies on the use of DBS for essential tremor highlight this
point. While Bekar et al. (2008) found that DBS may non-
synaptically activate adenosine A1 receptors, leading to a re-
duction in tremor activity, this neuromodulatory effect may be
specific to this pathology and thalamic targeting [185].
Understanding the molecular underpinnings of
neurostimulation will greatly advance the treatment of dis-
eases originating from or involving the cerebellum.
Expanding studies to simultaneously address the effects of
chronically implanting electrodes into the cerebellumwill also
deepen our knowledge of how to best treat diseases. It is
already known that metal electrodes can promote gliosis, scar-
ring, and prolonged inflammation, but can chronic implanta-
tion have any benefit [387]? Electrical stimulation may coun-
ter some of the negative effects of implantation, such as it can
modulate inflammatory responses [388], but can implantation
itself be additive and positively alter gene expression? It will
be interesting to discover what stimulation versus implanta-
tion does, in addition to resolving whether stimulation at dif-
ferent frequencies and locations have distinct benefits.
Solving these challenging problems will promote the design
and implementation of treatments and therapies for targeting
the many disorders with cerebellar involvement.
Consensus and Summary
We present 17 different sections reviewing data for what is
currently known about cerebellar stimulation in humans, non-
human primates, and rodent models. Based on studies of elec-
trical stimulation in the normal brain and in disease (human
and animal models), there is a general consensus that
stimulating the cerebellum has profound effects on behavior.
Still, from a therapeutic perspective, one has to ask (and
perhaps re-ask) the most direct and fundamental questions:
does cerebellar neurostimulation actually work? If yes, how
does it work?
Through previous experiences with cerebellar stimulation,
it seems evident that at least some patients were significantly
helped by these efforts, and that chronic cerebellar stimulation
can be done without undue risk (see sections by Wichmann
and DeLong). Clearly, stimulating the cerebellar cortex has a
powerful influence on the circuit, and the response conforms
to the structural framework within the cerebellar layers as well
as their interaction with the cerebellar nuclei (see section by
Heck). Cerebellar nuclei stimulation has similarly convincing
effects, particularly in the behavioral domain in which motor
and non-motor responses are modulated (see section by
Tanaka). However, does this mean that placing stimulating
electrodes into a cerebellar region alters the activity within
that region? This has been a challenging problem to address
since most often the stimulating current creates enough noise
that in vivo recording of the responses at the stimulation site
are masked. Based on analysis of neuronal activity in mice
that are genetically modified to exhibit dystonia, it is sug-
gested that stimulation indeed could have local effects on the
output properties of cerebellar neurons [63]. Although, is it
enough just to modulate cerebellar activity? Might there be
additional long-distance changes that occur after cerebellar
stimulation? The result of cerebellar stimulation in stroke cer-
tainly argues that cerebellar stimulation can induce plasticity
in regions as distant as the cerebral cortex (see section by
Cooperrider and colleagues) and these changes may be depen-
dent on specific molecular mechanisms (see section by Cheng
and colleagues). Even with this apparent specificity, it is dif-
ficult to rule out the possibility that stimulation could induce
several anterograde and retrograde effects, and they could be
local or long-distance [389]. For DBS, this leads us back to the
question that remains unanswered: what is the mechanism of
DBS? The general concept of DBS is that high-frequency
stimulation modulates erroneous neural activity and entrains
it to a pattern that normalizes behavior. There are a number of
possible mechanisms [390], but one perspective is that the
pulses produce inhibitory neuronal effects on somata that are
proximal to the location of the electrode. The inhibitory action
could be the direct result of a depolarization block through a
mechanism involving sodium channel inactivation and potas-
sium current potentiation. However, DBS might also increase
and regularize the output of the stimulated region by activat-
ing local axons—this is certainly an appealing hypothesis in
cerebellar disorders since much of electrophysiological de-
fects could stem from changes in the firing regularity of the
cerebellar nuclear neurons. At the network level, the end result
is that the entrainment overrides pathological oscillatory ac-
tivity. Perhaps cerebellar long distance connectivity and
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oscillations are key features that support DBS-mediated motor
improvements in ET (see section by Kuo and colleagues).
Again, given the potential dependence of cerebellar function
on neuronal synchrony, it could be that DBS ultimately serves
to normalize activity within an existing internal framework
that packages cerebellar circuits into distinct functional
modules.
Is the purpose of cerebellar stimulation to correct cerebellar
function itself, or is it more important that it improves its
functional connectivity with the remainder of the brain?
There is also a third possibility, which is that the most critical
outcome of cerebellar stimulation is to enhance connectivity
between other brain regions [391]. Testing these ideas could
be carried out using modern optogenetics approaches (see
section by Gornati and Hoebeek), but human non-invasive
stimulation has provided some important clues. Long-lasting
changes in motor and non-motor functions and the potential
benefits in stroke, ataxia, dystonia, and tremor would suggest
that cerebellar rTMS and tCDS approaches also induce chang-
es in connected brain regions (see sections by Manto and
Oulad Ben Taib, Bradnam and McCambridge, Popa and
Hallett, and Timmann and Nitsche). While there is a consen-
sus that cerebellar non-invasive stimulation is practical, rela-
tively easy to implement in most medical institutions, and is
relatively safe, there is also a consensus on several matters that
must be addressed. Blind, and when possible double-blind,
studies will have to be performed to solve the lack of repro-
ducibility across some studies and consideration should be
given to specificity and inter-individual differences that may
also determine the effects of non-invasive stimulation. For
example, one major difference between the tDCS and TMS
is that at commonly used and safely applied intensities, tDCS
does not trigger action potentials and therefore is less specific
in its effects than magnetic stimulation. This might contribute
to the lack of reproducibility between the tDCS and TMS
studies. As for DBS, the mechanism of action(s) is poorly
understood, and the full impact on global brain networks re-
main(s) unclear.
We have argued that the cerebellum should be considered
as a target for neurostimulation, especially when other brain
regions are, for whatever reason, not ideal. However, being
that the cerebellum is in its infancy as a therapeutic neurosur-
gical target, perhaps to play devil’s advocate for a moment, we
could ask why the cerebellum should not (yet) be considered.
There is a need to understand which regions of the cerebellar
cortex are best suited for different disease conditions, should
stimulation paradigms take into account zones, and when
should the cerebellar nuclei be considered instead? If the cer-
ebellum is a better target in particular cases, which nucleus
should be targeted? We have to consider that stimulating a
given nucleus might not only result in a specific outcome
because of its circuit connectivity, but also because each nu-
cleus could have a very different composition of
glutamatergic, GABAergic, and glycinergic neurons. It should
also be noted that diseases such as ataxia can have develop-
mental rearrangements in the circuitry [392], which means
that stimulating a certain target might not yield the predicted
outcome. Even if a desired location is theoretically ideal, what
is the evidence that the electrode, in the case of DBS, will
remain in place? We know from experimental studies in ro-
dents that while tetrodes maintain stability in regions such as
the hippocampus, there can be considerable drift in the cere-
bellum. This could be due to several factors such as curvature
of the cerebellum, shape of the overlying bone and sinuses,
tissue density, or its relatively weak mechanical attachment to
the rest of the brain via three pairs of fiber bundles, which all
could affect the proper anchoring of electrodes to the targeted
region. Current ongoing studies in human stroke patients (see
section by Cooperrider and colleagues) could help address
many of these concerns, in addition to determining the types
of electrodes that are most suitable for the cerebellum, and
what the long-term impact on the tissue is. That is, what type
of damage response is initiated locally within the
cerebellum—or by the cerebellum and then communicated
to connected regions—and are there any contraindications that
arise, and how might they be dealt with by troubleshooting
and modifying the approach?
Another major consideration, with its own hurdles, is if and
when to use brain stimulation in pediatric patients. The sheer
number of neurons and glia in the cerebellum, and its
protracted developmental timetable all contribute to its high
level of susceptibility to injury and disease. The diseases that
affect cerebellar development are many, including well-
known disorders such as ataxia (several forms), hydrocepha-
lus, medulloblastoma, cerebral palsy, preterm birth, and ASD.
Interactions and expression in gene networks are significantly
altered, and as a consequence the normal dynamics of mor-
phogenesis are abnormal. The normal dynamics of typical
cerebellar development already pose challenges for predicting
when it might be safe and effective to intervene with stimula-
tion, and with the added complexity of disease-induced
changes, the need for determining when and where the best
stimulation targets are, becomes even greater. That is, a rea-
sonable target at one time point during development may be
inappropriate at another time point because of structural and
functional changes based on neuronal migration, circuit con-
nectivity, synaptic plasticity, and gene expression. These bio-
logical properties of the cerebellum (and for that matter, all
brain regions) are core features for asking what ethical stan-
dards must be in place to consider stimulation in children,
especially for invasive approaches such as DBS.
Although cerebellar stimulation is not a new idea, its focus
has changed over the years. For instance, in 1809, stimulation
was used to understand the role of the cerebellum in behavior, as
evidenced by Rolando showing that galvanic stimulation of the
cerebellum could induce movement [393]. This experimental
Cerebellum
use of cerebellar stimulation to better understand cerebellar func-
tion was carried well into the 1940s [392]. From the 1950s to the
1980s, cerebellar stimulation gained more attention (albeit con-
troversial) for its use in the treatment of disease [156, 394–396].
There has now since been a major overhaul in the ethical stan-
dards throughout medical practice around the world, but there
are still many important scientific findings and ethical lessons to
draw upon from what researchers are now describing as a dark
era of neurosurgery [394]. Furthermore, advances in our under-
standing of cerebellar development, genetics, anatomy, and elec-
trophysiological properties provide an ever-growing number of
ideas towards which one can be enthusiastic about, especially
given the range of motor and non-motor functions that are now
attributed to normal cerebellar function. In addition, the technical
advances made in device and electrode design and neurosurgical
targeting techniques should encourage a revistation to cerebellar
stimulation for defined patient populations. Perhaps the firmest
consensus that we have come to is that studies of cerebellar
neurostimulation should proceed, but only with the sharpest crit-
ical eye for experimental and ethical standards, alternate expla-
nations, and the mechanisms of action for how each stimulation
paradigm works.
Concluding Remarks (R.V. Sillitoe)
As we continue to unravel the many functions and anatomical
connections of the cerebellum, including its unexpected roles in
non-motor function and its direct links to the basal ganglia, its
utility as a target for therapeutic neurostimulation will expand.
As a field, we should proceed with cautious optimism that the
cerebellum could be amuch-needed source of corrective signals
in a number of diseases. We look forward to further experimen-
tally testing whether cerebellar cortical, cerebellar nuclear, or
even cerebellar peduncular stimulation could be beneficial in
ataxia, dystonia, tremor (multiple forms), epilepsy, stroke, and a
growing list of disorders. Moreover, optogenetics and related
approaches suggest that perhaps circuit specific stimulation
could even be possible. We also look forward to further explor-
ing the efficacy of newly developed cerebellar stimulation par-
adigms, such as low-intensity focused ultrasound, in disease
[397]. Whatever clinical successes are achieved, we must con-
tinue to ask, how does neurostimulation work?
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